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ABSTRACT
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Identification of Factors Affecting Bovine Somatic Cell Nuclear Transfer
Efficiency and Characterization of Transcriptional Profiles
of Nuclear Transfer Embryos and Cotyledons
by
Kenneth Ivan Aston, Doctor of Philosophy
Utah State University, 2007
Major Professor: Dr. Kenneth L. White
Department: Animal, Dairy, and Veterinary Sciences
Since the production of the first sheep by somatic cell nuclear transfer a great deal
of effort has been made to improve efficiency and to understand nuclear reprogramming
mechanisms. Unfortunately efficiency remains low, and nuclear reprogramming
mechanisms remain uncharacterized. The objectives of this research were to identify
factors associated with somatic cell nuclear transfer efficiency and to analyze the
transcriptome of blastocyst-stage clone and control embryos and cotyledonary tissue in
an effort to elucidate mechanisms responsible for the low developmental efficiency and
high post-implantation losses.
The experiments reported here identify factors including oocyte source and timing
of activation following nuclear transfer that yield improved efficiencies. It was
determined the use of cow oocytes for somatic cell nuclear transfer results in improved in
vitro development and increased pregnancy rates. These data further indicate prolonged
exposure of the donor nucleus to pre-activated oocyte cytoplasm results in increased
nuclear fragmentation and reduced developmental efficiency in vitro.
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Several aberrantly expressed genes were identified in nuclear transfer
blastocysts and cotyledons that could impact cloning efficiency. Major histocompatibility
complex I and down-regulator of transcription 1 were overexpressed in nuclear transfer
blastocysts, and retinol binding protein 1 was overexpressed in nuclear transfer
cotyledons. The functions of these genes in immune response, transcriptional regulation,
and retinol binding and transport make them attractive candidates for further nuclear
transfer research.
Expression levels of six developmentally important genes were analyzed in
various stages of preimplantation nuclear transfer embryos by real-time polymerase chain
reaction to determine the timing of nuclear reprogramming following nuclear transfer.
Five of the six genes were aberrantly expressed multiple developmental stages, however
by the blastocyst stage only one gene was aberrantly expressed. These data indicate
reprogramming is delayed in nuclear transfer embryos resulting in over- or underexpression of developmentally important genes during early embryogenesis.
These experiments report factors associated with improved nuclear transfer
efficiency; provide insight into potential mechanisms for low developmental rates,
abnormal placentation, and fetal loss of clones; and characterize the timing of nuclear
reprogramming following somatic cell nuclear transfer.
(216 pages)
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CHAPTER 1
REVIEW OF LITERATURE
Cloning by nuclear transfer (NT) involves the removal of DNA from an oocyte,
yielding a cytoplast, followed by the transfer of foreign DNA (nucleus) into the cytoplast,
thus producing an oocyte with the full complement of DNA and the potential to produce
a living organism. Somatic cell nuclear transfer (SCNT) involves nuclear transfer with a
differentiated cell. While relatively simple in principle, SCNT requires a dramatic
remodeling and reprogramming of DNA following transfer of the differentiated cell or
nucleus into a host cytoplast in order for the DNA to be converted from its differentiated
state to a totipotent, embryonic state. Consequently, while research in the field of SCNT
continues at a rapid pace, understanding the mechanisms involved in the reprogramming
process as well as methods for improved efficiencies of SCNT development remain
somewhat elusive.
A Brief History of Cloning
The NT procedure was first devised by the German Nobel Laureate Hans
Spemann in 1938 when he proposed an experiment involving the insertion of a nucleus
into an enucleated oocyte. The idea was not pursued, however, because he did not have
the equipment required to perform such an experiment (Spemann 1938). Briggs and King
were the first to successfully utilize NT in the production of live offspring from metazoan
cells. They reported the successful production of Northern Leopard Frog, Rana pipiens,
tadpoles via NT in May of 1952 (Briggs and King 1952). Continued research by this
same group later concluded that developmental potential of NT embryos declined as cells
from increasingly more developed embryos were utilized for NT (King and Briggs 1956).
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In 1966 frog larval nuclei were used to successfully produce fertile Xenopus frogs
(Gurdon and Uehlinger 1966). The first attempts with SCNT in frogs provided evidence
that somatic cells from a variety of sources including skin (Gurdon et al. 1975),
lymphocytes (Wabl et al. 1975), erythrocytes (DiBerardino and Hoffner 1983),
leukocytes, and erythroblasts (Di Berardino and Orr 1992) were able to de-differentiate
and yield morphologically normal tadpoles, however none of these tadpoles survived to
adulthood. These results showed the potential of differentiated cells to derive numerous
different cell types in a complex organism; however, the question remained whether adult
cells could be reprogrammed back to totipotency.
Success with NT in mammals was not reported until the 1980’s. Initially
experiments involving the transfer of pronuclei from one mouse embryo to another
proved successful in producing live births, however they were unable to produce viable
embryos beyond the blastocyst stage using blastomeres from cleavage-staged embryos as
nuclear donors (McGrath and Solter 1984). Finally in 1986 Willadsen reported the
production of completely viable sheep embryos derived from the transfer of 8- and 16cell blastomeres to enucleated oocytes that result in the birth of live lambs (Willadsen
1986). In 1987, Prather et al. used essentially the same procedure to produce live cattle
(Prather et al. 1987). Over the next few years, a number of other species successfully
cloned from cells of preimplantation embryos followed including mice, rats, rabbits, pigs,
goats, and monkeys (Di Berardino 2001). In an effort to stretch the envelope of NT and
produce a larger number of genetically identical offspring, generational cloning or serial
NT was implemented (Stice and Keefer 1993; Westhusin et al. 1991; Willadsen 1989).
This technology involved producing embryonic clones then harvesting blastomeres from
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those first generation clones and producing a second generation of clones by the same
process. This could be repeated for several generations potentially resulting in several
thousand cloned embryos derived from a single embryo. With continuing advances in
nuclear transfer technology, the question remained: could offspring be produced by NT
from differentiated cells? A number of embryonic stem cell-like lines were produced
from mice (Piedrahita et al. 1990), cattle (Stice et al. 1996), sheep (Notarianni et al.
1991), and pigs (Notarianni et al. 1990), but attempts at producing cloned animals from
stem cell-like lines proved ineffective (Stice et al. 1996; Tsunoda and Kato 1993).
Based on early work with somatic cells and cultured stem cell-like cells it was
believed that it was not possible to produce viable offspring from adult cells; however, in
1994 Sims and First came a step closer reporting the successful production of cloned
calves using inner cell mass (ICM) cells cultured in vitro for up to 28 days (Sims and
First 1994). In 1996 Campbell et al. announced the production of five cloned sheep
derived from in vitro cultured, putative differentiated ICM cells (Campbell et al. 1996b).
The success with cultured cells was closely followed by the announcement of the birth of
Dolly, the first cloned animal derived from an adult cell (Wilmut et al. 1997). The
announcement of Dolly was significant in that it demonstrated a differentiated mammary
cell derived from an adult animal was able to be reprogrammed to an embryonic state and
give rise to a complete and healthy animal. Since the first successful SCNT experiments
in sheep, the technology has been applied in the production of a number of other species
including mice (Wakayama et al. 1998), cattle (Wells et al. 1999), goats (Baguisi et al.
1999), pigs (Polejaeva et al. 2000), mouflon sheep (Loi et al. 2001), rabbits (Chesne et al.
2002), mules (Woods et al. 2003), cats (Shin et al. 2002b), rats (Zhou et al. 2003), a deer
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(unpublished), horses (Galli et al. 2003b), a dog (Lee et al. 2005), and ferrets (Li et al.
2006b), and the list continues to grow.
Status of Somatic Cell Nuclear
Transfer Technology
While an incredible amount of research has focused on SCNT, and progress
continues, the molecular events underlying the successful conversion of a differentiated
somatic cell to a totipotent embryonic cell with the capacity to derive a healthy and
normal animal remain poorly understood. Further, the efficiency with which this process
occurs successfully remains very low. While it is difficult to ascertain the overall
efficiencies due to differences in protocols, embryo transfer criteria, and data presentation
the overall efficiency of SCNT across species based on the number of embryos produced
is believed to be less than 5% (Campbell et al. 2005). In cattle approximately 10-15% of
SCNT embryos transferred develop to term (Oback and Wells 2007).
In addition to the problems associated with poor efficiency following SCNT
including lower rates of development to the blastocyst stage in vitro (Chapter 2; Arat et
al. 2003; Bhuiyan et al. 2004) lower rates of pregnancy establishment (Hill et al. 2000;
Powell et al. 2004), and higher rates of pregnancy loss (Heyman et al. 2002) a number of
other differences between SCNT and control embryos and fetuses have been reported.
These include abnormal chromosome constitutions and higher incidence of aneuploidy in
SCNT embryos (Bureau et al. 2003; Shi et al. 2004), abnormal gene expression patterns
in SCNT embryos (Daniels et al. 2000; Han et al. 2003; Li et al. 2006a; Santos et al.
2003) and fetuses (Hill et al. 2002; Schrader et al. 2003), delayed and incomplete
demethylation followed by aberrant re-methylation of DNA in SCNT embryos and
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fetuses (Kang et al. 2001; Kang et al. 2002; Kang et al. 2003; Mann et al. 2003; Shi and
Haaf 2002; Young and Beaujean 2004) and altered patterns of histone acetylation in
SCNT embryos and fetuses (Enright et al. 2003; Enright et al. 2005; Santos et al. 2003),
and abnormal placentation often characterized by enlarged placentomes, edematious
membranes, and hypovascularization of placentomes (Constant et al. 2006; Heyman et al.
2002; Hoffert et al. 2005; Oishi et al. 2006). Given the complexity of the SCNT process,
it is not surprising that a variety of different factors can affect efficiency.
Factors Affecting SCNT Efficiency
The inefficiencies associated with SCNT likely stem largely from deficiencies in
the reprogramming process following NT. Following the transfer of a differentiated cell
or nucleus into an enucleated oocyte, the DNA must be reprogrammed from a cell-typespecific gene expression pattern to a totipotent embryonic-cell state. Modifications to the
epigenetic state of the DNA are required in order for this to occur.
Numerous factors can have an impact on the efficiency of nuclear reprogramming
following nuclear transfer. These factors include the state and source of the donor cell,
cytoplast source and quality, timing and methods of manipulation and activation, and
embryo culture conditions. Evaluation of the literature associated with SCNT suggests
that most if not all deficiencies associated with the low efficiency in cloning stem from
failures or deficiencies in epigenetic reprogramming.
State and Source of the Donor Cell
A variety of donor cell types have been utilized to successfully produce cattle by
SCNT including mammary (Kishi et al. 2000), adult and fetal skin (Hill et al. 2000), lung,
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muscle (Powell et al. 2004), and granulosa (Wells et al. 1999) cells. Some reports
indicate certain somatic cell types or culture conditions result in more efficient
development following SCNT (Batchelder et al. 2005; Collas et al. 1992; Kasinathan et
al. 2001; Lei et al. 2003; Powell et al. 2004), however there is no consensus as to the best
somatic cell type or culture conditions for SCNT (Campbell et al. 2005). It has been
proposed that cloning efficiency may be inversely correlated with the degree of donor
cell differentiation (Jaenisch et al. 2002; Oback and Wells 2002). This is supported by the
fact that embryonic cells and early fetal cells are generally more efficient in NT than
adult somatic cells (Oback and Wells 2007). Contrary to expectation, NT with stem cells
does not generally result in improved efficiency (Amano et al. 2001; Ono et al. 2001) and
in fact can result in reduced efficiency compared with differentiated cells (Sung et al.
2006). The reasons for the reduced efficiency of SCNT using adult stem cells are
unknown. Additional research is required in order to more fully characterize the factors
associated with donor cell epigenetic status that result in improved SCNT efficiency.
Attempts have been made to improve the efficiency of NT by manipulation of the
donor cell prior to NT. One approach is treatment of donor cells to change DNA
methylation or histone acetylation levels to more closely approximate levels found in in
vitro fertilized (IVF) embryos. The DNA methyl-transferase inhibitor 5-aza-2'deoxycytidine has been utilized to reduce DNA methylation levels in the transferred
nucleus, and Trichostatin A, a histone deacetylase inhibitor has been used to increase
histone acetylation (Enright et al. 2003; Enright et al. 2005; Shi et al. 2003). These
approaches have demonstrated reduced DNA methylation and increased histone
acetylation in preimplantation NT embryos, but to date, no report addressing the viability
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of transferred embryos exists. Synchronization of donor cells using roscovitine, a cyclin
dependent kinase 2-inhibitor has been reported to improve SCNT efficiency (Gibbons et
al. 2002; Miyoshi et al. 2006).
While it is clear donor cell type, culture conditions, and donor cell treatment can
affect the efficiency of SCNT embryo development, it remains unclear what cell types,
culture conditions and treatments result in the most efficient development following
SCNT and by what mechanism such factors impact development.
Cytoplast Source and Quality
The recipient cytoplast likely has a more profound impact on the success of NT
than the donor cell simply because it makes a more significant contribution to the
reprogramming process. This is supported by the observation that SCNT utilizing
fertilized oocytes or oocytes activated prior to NT does not support in vitro development
(Tani et al. 2001). In the early bovine embryo rRNA is not transcribed until the 4-cell
stage (Viuff et al. 1998), and high transcriptional activity is not observed until the 8- to
16-cell stage (Bilodeau-Goeseels and Panich 2002; Memili et al. 1998), so events of early
embryogenesis are almost completely dependent on maternal transcripts and oocyte
proteins. Differences in the developmental capacity of fetal, calf, and adult oocytes in
IVF experiments have been noted by several groups (Pujol et al. 2004; Rizos et al. 2005)
demonstrating important differences in developmental capacity depending on the source
of oocytes.
Little research has been done to evaluate the mechanisms by which differences in
oocytes result in altered SCNT outcomes; however, it has been well established that calf
oocytes differ from cow oocytes, and embryos derived from calf oocytes following IVF
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are less developmentally competent than IVF embryos resulting from cow oocytes
(Damiani et al. 1996; de Paz et al. 2001; Gandolfi et al. 1998; Khatir et al. 1998;
Levesque and Sirard 1994; Majerus et al. 2000; Revel et al. 1995; Salamone et al. 2001).
Studies of pre-pubertal calf oocytes have indicated they differ from cow oocytes
in several important ways. It has been reported that IVF embryos derived from calf
oocytes develop slower in vitro, arrest more frequently at the 9-cell stage, and exhibit a
longer lag phase before maternal to zygotic transition (Majerus et al. 2000). Calf oocytes
also undergo nuclear maturation at a slower rate than cow oocytes (Khatir et al. 1998).
Gandolfi et al. (1998) reported that calf oocytes are smaller in diameter, metabolize
glutamine and pyruvate at a lower rate during the first three h of IVM, and exhibit a
decline in protein synthesis earlier as compared with cow oocytes (Gandolfi et al. 1998).
Other groups have also reported different patterns of protein synthesis between cow and
calf oocytes (Gandolfi et al. 1998; Levesque and Sirard 1994; Salamone et al. 2001). Calf
oocytes contain more microvilli on their cell surface and more endocytic vesicles than
cow oocytes, while cow oocytes contain a larger superior mitochondrial population than
calf oocytes (de Paz et al. 2001). Numerous reports have indicated that fewer calf oocytes
develop to blastocyst as compared with cow oocytes in IVF, parthenogenetic, and NT
experiments (Damiani et al. 1996; Levesque and Sirard 1994; Majerus et al. 2000; Revel
et al. 1995; Salamone et al. 2001). Additional work by Revel et al. (1995) indicated that a
much lower pregnancy rate results from the transfer of blastocysts derived from calf
oocytes (1 of 23 recipients; 4%) compared to cow-oocyte-derived blastocysts (10 of 26
recipients; 38%). In this experiment, the single pregnancy established from calf embryos
resulted in a full-term live calf (Revel et al. 1995). This indicates that although the overall
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developmental competence of calf oocytes is much lower, some oocytes derived from
pre-pubertal animals do have the capacity to direct development to term.
While many studies have evaluated the differences in developmental competence
between cow and pre-pubertal calf oocytes fertilized in vitro, less attention has been
given to potential differences between cow and heifer oocytes. There are several reports
of differences between cow and heifer oocytes in terms of numbers of oocytes per ovary
and in vitro developmental efficiency. Researchers have reported fewer oocytes collected
from cows than from heifers following slaughter (Moreno et al. 1992) and also in
conjunction with ovum pick up (Rizos et al. 2005). Researchers also compared the
number and quality of oocytes from slaughtered crossbred beef heifers under 30 months
and cows over 4 years old (Rizos et al. 2005). There were no differences observed in the
number of oocytes collected per ovary; however, following IVF significantly more cow
oocytes developed to the blastocyst stage on day 8 as compared to heifer oocytes (46.5%
and 33.4%, respectively). In their experiment, heifer oocytes were further divided into
groups based on the age of the donor (12-18 months, 19-24 months, and 25-30 months).
There was no difference in development to the blastocyst stage between the three age
groups (35.0%, 35.2%, and 36.5%, respectively). The superiority of cow oocytes over
heifer oocytes in terms of development to blastocyst following IVF (27.5% and 16.4%,
respectively) was also reported (Zhang et al. 1991). One group evaluated the
developmental potential of oocytes collected from cows of different ages and found no
significant difference in blastocyst yield between oocytes from 1-3 year old cows
compared with oocytes from cows older than 3 years (Mermillod et al. 1992). A study
involving the collection of oocytes from a slaughtered, Bovine Spongiform
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Encephalopathy (BSE)-infected herd also compared development to the blastocyst
stage using oocytes collected from heifers and cows. Cow oocytes developed into gradeone blastocysts at a slightly higher efficiency than heifer oocytes (14.6% and 10.2%
respectively) however the difference was not significant (Galli et al. 2003a).
In addition to the scarcity of research evaluating the developmental competence
of heifer oocytes, very little research has been done to evaluate the effect of oocyte
source on bovine SCNT. Two studies have evaluated the developmental competence of
calf oocytes used in SCNT. Both reported lower rates of development to the 2-cell and to
blastocyst stages compared with development using cow oocytes. In one study, cleavage
of NT embryos was 75% with cow oocytes and 69% with calf oocytes, and blastocyst
development was 21% and 9% respectively (Mermillod et al. 1998). A second study
reported cleavage rates of 67% and 22% and blastocyst rates of 20% and 5% using cow
and calf oocytes, respectively (Salamone et al. 2001).
In the environment of the recipient cytoplast following NT, the donor nucleus
undergoes dramatic changes that result in the restoration of totipotency to a differentiated
nucleus in a process referred to as nuclear reprogramming.
The same machinery that is involved in chromatin modifications following
fertilization is likely recruited for reprogramming of the donor nucleus following NT.
Nuclear reprogramming of the donor cell following SCNT involves nuclear envelope
breakdown (NEBD) and premature chromosome condensation (PCC; Barnes et al. 1993;
Campbell et al. 1996a; Czolowska et al. 1984), followed by erasure of epigenetic
modifications to DNA including changes in histone acetylation (Nakao 2001) and DNA
methylation (Kang et al. 2003; Shi et al. 2003). Since maternal transcripts are responsible
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for the events of early embryonic development (Telford et al. 1990), and given the
events that occur naturally following fertilization, nuclear reprogramming is likely
mediated by factors in the oocyte cytoplasm emphasizing the importance of selecting
optimal oocytes for SCNT. While the effect of oocyte source and status on SCNT
efficiency have not been extensively studied it is clear that these factors can have a
profound impact on success. Indeed, the duration of in vitro maturation (Zakhartchenko
et al. 2001), the exposure time of the donor nucleus to oocyte cytoplasm (Wells et al.
1998), and differences in mitosis/meiosis/maturation-promoting factor (MPF) and
mitogen activated protein (MAP) kinase levels within the oocyte (Lee and Campbell
2006) have all been demonstrated to impact SCNT efficiency. MAP kinase within the
oocyte has been shown to be involved in a number of different epigenetic reprogramming
processes including histone deacetylase phosphorylation (Galasinski et al. 2002), histone
H3 phosphorylation (Clayton and Mahadevan 2003) and changes in histone acetylationdependent DNA methylation (Gregory et al. 2001). With the extensive involvement of
the oocyte cytoplasm on nuclear reprogramming it is clear that the oocyte can have a
profound impact on SCNT efficiency.
Oocyte maturation is another important factor in successful SCNT. As expected,
in vivo matured oocytes have been shown to perform better for SCNT than in vitro
matured oocytes (Wells et al. 1997), however collection of in vivo matured oocytes from
livestock species is labor intensive, not cost effective, and therefore impractical for
application in most SCNT programs. Continued research on the effect of oocyte source as
well as maturation conditions on SCNT efficiency is required, along with further research
to elucidate mechanisms associated with specific aspects of reprogramming.
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Methods of Manipulation and Activation
A great deal of research has evaluated numerous manipulation and activation
protocols in an effort to develop methods resulting in improved SCNT efficiencies.
SCNT typically involves the removal of DNA from a mature oocyte (enucleation)
followed by the injection of a donor cell or nucleus either in the perivitelline space (donor
cell), the space between the oocyte plasma membrane and the zona pellucida, or directly
into the oocyte cytoplasm (nucleus). Injection of the cell into the perivitelline space
requires a subsequent fusion step in order to fuse the donor cell and oocyte membranes
and introduce the donor nucleus into the oocyte cytoplasm. Usually following, but
sometimes preceding NT, activation of the embryo is required in order to signal the
oocyte to initiate cell division. In the case of natural fertilization, the interaction between
the sperm and the oocyte triggers this activation event, but with SCNT a synthetic
activation is required. A variety of methods have been employed for manipulation and
activation of SCNT embryos with varying degrees of success.
The most common method for enucleation employs the use of a small polished
glass holding pipette to keep the oocyte stationary and an enucleation pipette that is used
to pierce the zona pellucida and plasma membranes and aspirate both the DNA within the
cytoplasm of the oocyte and the associated first polar body (Li et al. 2004). Other
methods include chemically-induced enucleation using etoposide (Elsheikh et al. 1998),
etoposide in conjunction with cycloheximide (Fulka and Moor 1993), and ethanol with
demecolcine (Ibanez et al. 2003). While these methods greatly facilitate the enucleation
process, development of NT embryos following chemically-induced enucleation remains
lower than development of mechanically enucleated oocytes (Gasparrini et al. 2003).

13
Zona-free cloning methods have also been employed successfully in bovine and
porcine SCNT (Oback et al. 2003; Peura 2003; Vajta et al. 2001). This method does not
require micromanipulation and has the potential to be automated, but the culture
requirements for zona-free embryos are more problematic than for manually manipulated
embryos and for this reason has not found wide acceptance in the field (Vajta et al. 2005).
Researchers have evaluated the effect of manipulation and activation of oocytes in
various stages of meiosis on SCNT efficiency. Two predominant methods have been
successfully utilized for NT. The first is a protocol in which the donor nucleus is
transferred into a pre-activated, enucleated cytoplast. The other protocol involves the
transfer of a donor nucleus into a metaphase II (MII)-arrested cytoplast followed by
subsequent activation. The latter protocol results in much more efficient development to
blastocyst in bovine NT and is therefore most frequently used (Shin et al. 2002a). The
extremely low in vitro efficiency using pre-activated cytoplasts has precluded the transfer
and pregnancy evaluation of pre-activated SCNT embryos so no data exist reporting posttransfer developmental potential.
In addition to the effects of manipulation methods and timing of the NT on SCNT
efficiency, timing and method of activation has been shown to impact efficiency. Several
groups have shown that the duration of exposure of the donor nucleus to oocyte
cytoplasm affects in vitro development. Exposure of transferred nuclei to cytoplasm for
less than 30 min prior to activation yielded significantly lower blastocyst development
than 2 h exposure (Liu et al. 2001). However, excessive exposure of the donor DNA to
oocyte cytoplasm results in lower rates of in vitro development in cloned embryos (Akagi
et al. 2001). Most recently, Choi et al. demonstrated that in vitro development of bovine
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NT embryos to blastocyst decreased as time in hold was increased from one to five h
(Choi et al. 2004). However, little data exist indicating the viability to term of SCNT
embryos based on timing of activation following exposure of the transferred nuclei to
recipient cytoplasm until publication of results contained in this dissertation. The
mechanisms underlying the differences observed in development rates based on the
duration of cytoplasmic exposure prior to activation remain obscure.
Following normal fertilization, activation by the sperm elicits regular, repetitive
intracellular calcium transients. Activation results in resumption of meiosis, cortical
granule release, decondensation of the sperm nucleus, and formation of male and female
pronuclei. As the donor cell does not have the capacity to activate the oocyte, artificial
means of activation are required. Early on it was discovered that mature oocytes could
undergo parthenogenetic activation in the absence of the male gamete using a number of
physical and chemical methods (Kaufman and Gardner 1974). A number of
parthenogenetic activation protocols have been applied successfully to SCNT. A short,
high voltage electrical pulse can be used to create transient pores in cellular membranes
allowing the influx of calcium from extra-cellular pools (Zimmermann and Vienken
1982). Treatment with Ca2+ ionophores such as ionomycin result in the influx of Ca2+ as
well as the release of Ca2+ from intracellular stores (Steinhardt et al. 1974). Exposure of
the embryo to 7% ethanol has been used in mice to induce Ca2+ release and activation
(Ilyin and Parker 1992). Inhibition of protein synthesis using agents such as
cycloheximide or puromycin induces activation in mouse (Siracusa et al. 1978) and
human oocytes (Balakier and Casper 1993), however more efficient activation occurs
with a combination of calcium stimulus in conjunction with protein synthesis inhibition
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(Presicce and Yang 1994; Tanaka and Kanagawa 1997). While a number of methods
have been demonstrated for activation of bovine SCNT embryos, none of the present
alternatives closely mimic physiological activation following fertilization, and none stand
out as being significantly better than the rest (Atabay et al. 2003; Bhak et al. 2006; Hill et
al. 1999a; Yamazaki et al. 2005). Substantial research evaluating the post-transfer
developmental potential of SCNT embryos generated by different activation protocols is
lacking. There is certainly a need for continued and substantially more research effort
evaluating the long term developmental impacts of various oocyte activation protocols in
SCNT outcomes.
Embryo Culture
Another critical and relatively deficient component in the SCNT process is
embryo culture. Following NT and activation, bovine embryos are generally cultured in
vitro for 6-7 day prior to transfer. To date no in vitro embryo culture system rivals in vivo
culture in terms of development efficiency and embryo quality when considering the
outcome of any assisted reproduction approach. Bovine SCNT embryos have been
successfully cultured in a number of different media. Typical media used for bovine
SCNT include CR1aa (Rosenkrans and First 1994), Synthetic Oviductal Fluid (SOF)
(Brandao et al. 2004), and G1/G2 medium (Krisher et al. 1999). Attempts to improve in
vitro development efficiency of bovine IVF and SCNT embryos have resulted in a wide
variety of culture media and culture environments. The use of a monolayer of co-culture
cells was shown in the mid-1980s to improve the developmental rates of both in vivo- and
in vitro-produced bovine embryos cultured for various periods of time (Kuzan and
Wright 1982). Fukui determined in 1991 that embryos not cultured with co-culture cells
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grew better in environments with less than 20% oxygen (Fukui et al. 1991). While
great strides have been made to improve bovine embryo culture conditions, culture
conditions remain sub-optimal for both IVF embryos and SCNT embryos. Currently,
under the best conditions, rates of development of bovine IVF and SCNT embryos to
blastocyst remain about 40%. Even more troubling is the more frequent occurrence of
complications during pregnancy associated with in vitro-cultured embryos as compared
with in vivo-produced (IVP) embryos. While increased occurrence of complications
during pregnancy is likely associated with in vitro culture, the problems occur more
frequently in SCNT pregnancies than in IVF pregnancies. Increased incidences of large
offspring syndrome (LOS), characterized by abnormally large fetuses, extended gestation
length, and difficult parturition, and hydrallantois, a condition associated with excessive
accumulation of allantoic fluid, have been associated with both IVF and SCNT
pregnancies (Young et al. 1998), however the severity and frequency of both LOS and
hydrallantois is significantly greater following SCNT (Constant et al. 2006; Hill et al.
1999b; Lawrence et al. 2005). The problems common to IVF and SCNT pregnancies are
most likely a consequence of the in vitro culture conditions and specifically the presence
of serum or bovine serum albumin (BSA) in the culture medium (Lazzari et al. 2002).
These observations have provided increased impetus to develop completely
defined media and further improved culture conditions in which to culture embryos (Lim
et al. 2007). The elimination of the need for co-culture cells, serum, and BSA, which
introduce variability as well as many uncharacterized factors into the culture, has been a
focus of much research. Sequential media such as G1/G2 in which different media are
used at different stages in the culture process are also being developed in an effort to
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further mimic physiological conditions. Despite the progress made thus far, suboptimal embryo culture conditions remain a contributing problem to the inefficiencies
associated with SCNT.
Epigenetics
Epigenetics refers to stable and heritable changes in gene expression beyond the
scope of conventional genetics. In other words, gene expression in a cell is not controlled
exclusively by the DNA sequence, but also by these stable “epigenetic” influences to
specific genes (Jaenisch and Bird 2003). In addition to their importance in differentiation
of tissue types during development, epigenetic alterations can also arise randomly or as a
result of environmental influence (Issa 2000). The genome adapts to developmental or
environmental cues either by post-synthetic modification to DNA or by modification of
proteins associated with DNA. It is believed that epigenetic modifications have arisen
and evolved as a genome defense against viruses and other parasitic sequences (Matzke
et al. 1999). Cellular differentiation occurs as a consequence of epigenetic modifications
imposed upon the genome. These epigenetic modifications direct the expression patterns
of cell-type-specific genes; therefore SCNT necessitates the reprogramming of the donor
cell carrying cell-type specific epigenetic modifications in order for every cell type to be
derived from a once-differentiated donor cell. It is widely believed that incomplete or
improper epigenetic reprogramming following SCNT results in the low efficiency as well
as the phenotypic problems observed in clones.
Epigenetic Mechanisms
A variety of epigenetic modifications to DNA and its associated proteins have
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been characterized. These modifications can serve either to silence expression or to
enhance transcription of specific genes. Predominant epigenetic modifications include
DNA methylation, and modifications to histones including methylation, acetylation,
ribosylation, phosphorylation, and ubiquitination.
DNA methylation. In 1975, Holliday and Pugh suggested DNA methylation might
be a mechanism whereby a stable pattern of gene expression is maintained through
mitosis (Holliday and Pugh 1975). More recently, it has been shown that methylation of
DNA usually, though not always, has a silencing effect on chromatin (Wolffe and Matzke
1999). Methylation is a post-synthetic modification that generally occurs at the 5’position of cytosines of the CpG dinucleotide.
While the protein(s) involved in active demethylation during early development
have not yet been characterized, several proteins have been implicated in cytosine
methylation (Jaenisch and Bird 2003). These DNA methyltransferases (Dnmt) function to
methylate cytosines by catalyzing the transfer of CH3 from S-adenosylmethionine to
carbon 5 of cytosine (Strathdee and Brown 2002). The methyltransferase family includes
Dnmt 1, Dnmt 1o, Dnmt 2, Dnmt 3a, Dnmt 3b, and Dnmt 3L.
Some understanding of the functions of these proteins has been gained through
the study of mice with mutations of the various Dnmt genes. Dnmt 1 (Li et al. 1992) and
the oocyte-specific isoform Dnmt 1o (Howell et al. 2001) exhibit a high binding affinity
for hemi-methylated DNA and are responsible for the maintenance of methylation on the
newly synthesized strand of DNA. A mutation in Dnmt 2 (Okano et al. 1998) yields no
phenotypic change, perhaps owing to a redundancy in the developmentally critical system
of DNA methylation. In Drosophila Dnmt 2 has been shown to have non-CpG
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methylation activity (Lyko et al. 2000). Dnmt 3a and Dnmt 3b (Okano et al. 1999) are
present at high levels in the early mouse embryo and are responsible for global de novo
methylation subsequent to active and passive demethylation in the paternal and maternal
genomes, respectively following fertilization. Dnmt 3L functions in concert with Dnmt
3a and Dnmt 3b in establishing proper maternal imprinting (Bourc'his et al. 2001).
It is still somewhat unclear how the seemingly minor modification of DNA
methylation can have such a profound impact gene expression. There are several
proposed models for its influence: methylation may prevent the binding of protein
regulators to their targets, involvement of regulatory proteins that bind only to methylated
DNA, or methylation of DNA changes its structural properties (Urnov and Wolffe 2001).
There is data to suggest that all three models may play roles, but regulatory
proteins that bind only methylated DNA have been studied most extensively. A group of
four proteins known as methylated-DNA binding domain proteins (MBD1-MBD4) have
been shown to preferentially bind to the CpG dinucleotide in which the cytosine is
methylated (Hendrich et al. 2001). MBD1, MBD2, and MBD3 function as transcription
repressors (Bird and Wolffe 1999), while MBD4 is a protein involved in mismatch repair
(Hendrich et al. 1999). Gene targeting in mice of different Mbd genes results in effects
ranging in severity from defective maternal behavior to lethality depending on the MBD
targeted (Hendrich et al. 2001).
Histone modifications. In addition to DNA methylation as an epigenetic
modification, histone modifications also function as epigenetic marks to the genome.
Covalent modifications to histones such as methylation, acetylation, phosphorylation,
ADP ribosylation, and ubiquitination have a direct impact on chromatin structure, which
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in turn acts as a modulator of gene expression (Goll and Bestor 2002). Histones are the
primary proteins responsible for the packaging of genomic DNA. The basic repeating
unit of chromatin is the nucleosome. The nucleosome consists of 146 bp of DNA
wrapped around a core composed of eight histones- two copies each of H2A, H2B, H3,
and H4 (Kornberg and Lorch 1999).
Post-translational modifications to histones are mediated by histone-modifying
and chromatin-modifying enzymes. Examples of these enzymes are histone
acetyltransferases (HATs), deacetylases (HDACs), and histone methyltransferases
(HMTs). The complex array of histone modifications observed experimentally gave rise
to the histone code hypothesis- the idea that histone modifications may be interdependent
and together they impact chromatin structure in such a way as to affect gene activation or
inactivation (Strahl and Allis 2000). Each of the four core histones can be modified at a
variety of sites. The number of different modifications and the multiple sites at which the
modifications can occur yields an incredibly large number of possible combinations,
which has made characterization of the histone code quite difficult.
Genomic imprinting. Epigenetic modifications are also responsible for genomic
imprinting, a mechanism whereby one of the two copies of a gene within a genome is
silenced and only one remains active. At least 45 imprinted genes have been identified in
the mouse, and of these genes, about 80% are clustered with other imprinted genes.
Initially, imprints are established during spermatogenesis and oogenesis. After
fertilization, while most genes are demethylated and re-methylated, imprinted genes
maintain their native methylated or demethylated state throughout the reprogramming
process. During early embryonic development, the imprints are erased in the germ cells
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then re-established later in development (Reik et al. 2001).
As with other epigenetic modifications, genomic imprinting probably arose in
response to parasitic DNA. It is possible that gene sequences located near these regions
of foreign DNA were silenced as an extension of the normal epigenetic silencing of
neighboring sequences. Imprints established in this way that conferred a selective
advantage were propagated, and others were eliminated (Barlow 1993).
X-chromosome inactivation. An interesting epigenetic mechanism has evolved in
mammals to compensate for differences in X-linked gene dosage between males (XY)
and females (XX). In placental mammals and marsupials, one of the X chromosomes is
inactivated by modification of chromosome architecture. The modifications that
inactivate the chromosome include DNA methylation and histone deacetylation.
Interestingly, the decision of which X-chromosome to inactivate in the embryo proper is
random, whereas in extra-embryonic tissues, the paternal X is always chosen for
inactivation (Park and Kuroda 2001).
Epigenetic Reprogramming
Following Fertilization
A dramatic demonstration of the dynamic involvement of epigenetics in
development is demonstrated by the reprogramming events that occur during germ cell
and early embryonic development in mammals. During germ cell development the
genomes of both the sperm and the egg are globally demethylated then re-methylatedprior to meiosis in the male (Davis et al. 2000) and during the oocyte growth phase of
meiotic arrest in the female, so that prior to fertilization, sperm and egg genomes are
much more highly methylated than somatic cells (Obata et al. 1998). At fertilization,
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sperm chromatin is actively demethylated, possibly by direct removal of the methyl
group from the cytosine (Bhattacharya et al. 1999) or by exchange of the 5methylcytosine with unmethylated cytosine via base excision (Weiss et al. 1996). The
mechanisms responsible for active demethylation of the paternal genome following
fertilization remain uncharacterized (McLay and Clarke 2003) although enzymatic
catalysis is most likely involved (Morgan et al. 2005). The maternal genome is also
demethylated during early development, but in a passive, replication-dependent manner,
such that the original DNA retains its methylation, but newly replicated strands are not
methylated. This global demethylation is subsequently followed by de novo methylation
of the genome starting at the 8- to 16-cell stage in bovine embryos and the blastocyst
stage in mice resulting in differentiation of cell lineages during development (Reik et al.
2001).
The successes achieved following SCNT suggest the same oocyte components
that are involved in the reprogramming events observed following fertilization can also
be utilized to de-differentiate a somatic cell and return it to a totipotent embryonic state.
The epigenetic modifications to the chromatin of a fibroblast distinguish it from an
embryonic cell or any other cell type. Following SCNT, the epigenetic state of the donor
cell is reprogrammed such that its epigenetic state closely resembles that of an embryonic
cell.
Epigenetic Reprogramming
Following SCNT
Epigenetic reprogramming is essential in order for SCNT be successful. During
nuclear reprogramming epigenetic marks are erased from the donor nucleus genome,
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resulting in an erasure of tissue-specific gene expression patterns effectively resetting
the cell to a totipotent state (Santos and Dean 2004). Studies evaluating the epigenetic
status of embryos following SCNT have demonstrated deficiencies in epigenetic
reprogramming frequently occur. These deficiencies are made manifest in several ways
including changes in histone modifications, DNA methylation patterns, and gene
expression.
Several studies have evaluated differences in epigenetic modifications following
SCNT. Hypermethylation of lysine 9 on histone H3 (H3-K9) as well as DNA
hypermethylation was reported in the majority of bovine preimplantation SCNT embryos
in one study (Santos et al. 2003). A number of studies evaluating the reprogramming
dynamics of epigenetic modifications in vitro following NT have also been reported.
Evaluation of DNA methylation patterns in developing NT embryos indicates
demethylation and remethylation events are not always faithfully recapitulated in the
mouse (Chung et al. 2003; Mann et al. 2003; Shi and Haaf 2002) and the cow (Bordignon
et al. 2001; Dean et al. 2001; Kang et al. 2002). It is also clear that histone acetylation is
sometimes aberrant in bovine SCNT embryos (Enright et al. 2003). This incomplete
epigenetic reprogramming is the predominant explanation for the frequent aberrant gene
expression in NT embryos and the subsequent failures in development (Santos et al.
2003).
Immunofluorescent staining of bovine NT embryos with an antibody directed
against 5-methyl-cytosine by Dean et al. (2001) demonstrated the occurrence of active
demethylation of the donor chromatin shortly after fusion similar to the active
demethylation of sperm chromatin observed following fertilization (Dean et al. 2001).
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However, de novo methylation occurred starting in 4-cell NT embryos as compared to
normal bovine embryos, which exhibit de novo methylation at the 8- to 16-cell stage
(Dean et al. 2001; Reik and Dean 2001). The enzymes responsible for DNA
demethylation may follow a pattern of activity similar to maturation promoting factor
(MPF) with high activity prior to activation and a diminishing of activity following
activation. Further research will be required to determine those dynamics, but based on
one study there appears to be a critical window of time in which active demethylation can
occur following fusion (Dean et al. 2001). The idea of this critical window between
fusion and activation is supported by the work of Bourc'his et al. (2001) in which active
demethylation was not observed when activation was performed at the time of fusion
(Bourc'his et al. 2001).
Other studies have focused on epigenetic reprogramming of specific genes
following SCNT. Evaluation of methylation patterns of imprinted genes following SCNT
indicates methylation errors at imprinted loci are common (Humpherys et al. 2002; Mann
et al. 2003; Mann et al. 2004). In addition, errors in X-inactivation (Eggan et al. 2000;
Jiang et al. 2007; Xue et al. 2002) and failures to activate important pluripotency genes
have been observed in SCNT embryos (Boiani et al. 2002; Bortvin et al. 2003). Critical
errors in the fundamental epigenetic state of chromatin during early development
following SCNT are likely the foundation for the numerous other deficiencies observed
in clones (Fulka and Fulka 2007).
Nuclear Organization and Gene
Expression Following SCNT
In addition to the requirement for correct epigenetic reprogramming, it is also
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necessary that a diploid chromosome constitution be maintained to ensure proper
development. In order for proper ploidy to be maintained in a NT embryo, donor cell
chromosomes must be condensed prior to activation, and following activation, a single
pronucleus should appear as the chromatin decondenses in preparation for DNA
replication.
MPF is an enzyme that is highly active in the MII oocyte and is a key factor in
nuclear remodeling prior to activation or fertilization. MPF is a protein kinase composed
of two proteins, cyclin and p34cdc2 (Gautier et al. 1990). The active kinase is responsible
for the resumption of mitosis or meiosis. Prior to activation or fertilization in the MIIarrested oocyte, MPF activity is high then following activation its activity declines
rapidly (Campbell et al. 1993a). Several significant morphological changes occur in the
donor nucleus following NT into cytoplasts with high MPF activity. These changes
include NEBD and PCC (Campbell et al. 1996a; Czolowska et al. 1984). Following these
two events, the nuclear envelope is reformed, and DNA synthesis commences (Campbell
et al. 1993b).
NEBD is essential for cytoplasmic spindle microtubules to gain access to
chromosomes prior to resumption of meiosis or mitosis. MPF, at least in part, facilitates
the breakdown of the nuclear membrane by phosphorylation of nuclear lamins resulting
in their depolymerization (Peter et al. 1990). Phosphorylation of nuclear pore complex
subunits further destabilizes the nuclear envelope (Macaulay et al. 1995). More recently it
has been proposed that mechanical tearing of the lamina by microtubules might work in
conjunction with phosphorylation events to break down the nuclear envelope (Beaudouin
et al. 2002).
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As the name implies, PCC involves the condensation of chromatin, which
occurs prematurely in the donor nucleus. It has been demonstrated that when an s-phase
nucleus undergoes PCC, the chromatin appears pulverized (Schwartz et al. 1971).
Additionally, an increased incidence of chromosomal abnormalities in s-phase nuclei that
underwent PCC has been reported (Collas et al. 1992). Several studies have reported
problems with nuclear organization and ploidy following SCNT (Alberio et al. 2001; Li
et al. 2005; Wakayama et al. 2003).
In addition to problems associated with nuclear organization following SCNT, a
number of groups have reported aberrant expression of genes in SCNT embryos and
fetuses, an additional manifestation of incomplete or improper epigenetic
reprogramming. One study used microarray analysis to compare global gene expression
profiles of bovine somatic donor cells, SCNT blastocysts, IVF blastocysts, and IVP
blastocysts. Based on these studies it was determined that a significant amount of
reprogramming has occurred by the blastocyst stage as SCNT expression profiles
resembled profiles for control embryos generated by IVF and artificial insemination (AI)
much more closely that their progenitor donor cells (Smith et al. 2005). The study
reported 50 genes differentially expressed between SCNT and IVP blastocysts, an
indication that, while a substantial amount of reprogramming has occurred properly in the
conversion of a somatic cell epigenetic pattern to that of an embryo; there are still
deficiencies in the reprogramming process. Another study evaluated the transcriptome of
mouse SCNT and IVP embryos during the first two cell cycles. During the second cell
cycle over 1000 genes were differentially expressed in SCNT embryos indicating the
reprogramming process occurs over several cell cycles, and the divergence in gene
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expression patterns narrows greatly by the blastocyst stage (Vassena et al. 2007a).
Numerous other studies report aberrant gene expression in SCNT embryos (Beyhan et al.
2007; Li et al. 2006a; Vassena et al. 2007b), placentas (Oishi et al. 2006; Patel et al.
2004), conceptuses (Moore et al. 2007; Schrader et al. 2003), and neonates (Jiang et al.
2007; Li et al. 2007).
Summary
A great deal of research and effort has been focused on SCNT over the past
decade, and while progress continues, SCNT is still very inefficient in terms of rates of
development in vitro and to a greater extent survival to term. A growing body of data
supports the idea that a common thread between nearly all deficiencies associated with
SCNT is inappropriate epigenetic reprogramming of the somatic cell nucleus as manifest
by genes being expressed when they should not be, not expressed when they should be,
or most commonly expressed at altered levels. The efficiency and fidelity with which
epigenetic reprogramming occurs is undoubtedly affected by all of the factors discussed
in this review including factors associated with the donor cell and cytoplast, manipulation
and activation procedures, and embryo culture conditions. An increased understanding of
how each of these factors impacts epigenetic reprogramming and further improvements
in each of these areas will continue to result in increased SCNT efficiency.
Research Goals and Possible Applications of Project
The focus of my research includes two primary objectives associated with bovine
SCNT; first to characterize factors associated with the process of SCNT that impact
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efficiency, specifically oocyte source and activation timing, and second to characterize
gene expression differences between SCNT and control embryos and placental tissues.
In the first objective I determined that the use of oocytes derived from cows in
SCNT results in greatly improved rates of development to term compared with heifer
oocytes. I also found that prolonged exposure of the somatic nucleus to oocyte cytoplasm
prior to activation results in nuclear fragmentation and reduced embryonic viability.
The subsequent gene expression studies revealed a variety of genes
inappropriately expressed in SCNT embryos and placentomes. Global gene expression
analysis of SCNT and AI blastocysts as well as fibroblast donor cells substantiated
previous findings as well as revealed a novel subset of aberrantly-expressed genes in
SCNT embryos. Microarray analysis of the fetal component of the placenta associated
with maternal/fetal nutrient exchange, the cotyledon, revealed a smaller subset of
differentially expresses genes. Of note, major histocompatibility complex I and downregulator of transcription 1 were overexpressed in SCNT embryos and retinol binding
protein 1 was overexpressed in SCNT cotyledons.
Comparisons of embryonic and fibroblast transcriptomes provided a large list of
differentially expressed genes from which six developmentally important genes were
selected for more detailed analysis. For this analysis Quantitative Reverse Transcriptase
PCR (Q-RT-PCR) was utilized to evaluate the expression levels of genes in various
stages of SCNT and IVF. For five of the six genes analyzed, aberrant expression was
detected in multiple developmental stages, however by the blastocyst stage only one gene
was aberrantly expressed in nuclear transfer embryos. This data indicate reprogramming
is delayed in nuclear transfer embryos resulting in over- or under-expression of
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developmentally important genes during early embryogenesis however the majority of
aberrant expression is rectified by the blastocyst stage. These experiments provided a
detailed analysis of reprogramming dynamics following SCNT for a group of
developmentally important genes.
Somatic cell nuclear transfer offers promise for many different applications
including rescue of endangered species, production of animals with genetically superior
traits, biopharmaceutical production, xenotransplantation applications, and stem cell
production. As SCNT efficiency increases the utility of the process will lend to further
advances in these applications. In addition, an understanding of the factors that affect
SCNT efficiency will offer insights into the complex and poorly understood field of
epigenetic reprogramming. The complex processes by which epigenetic modifications are
initiated and propagated and the mechanisms by which these modifications effect gene
expression are beginning to be characterized. There remains, however, much to be
learned in this area including understanding how specific environmental cues function to
bring about epigenetic changes and how specific genes are targeted for silencing or
activation by epigenetic controls. Continued research in the field of epigenetics will
undoubtedly open doors to increased understanding in many related fields.
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CHAPTER 2
THE DEVELOPMENTAL COMPETENCE OF BOVINE NUCLEAR
TRANSFER EMBRYOS DERIVED FROM COW
VERSUS HEIFER CYTOPLASTS 1
Abstract
Due to its economic importance, the production of cattle by nuclear transfer has
been a primary research focus for many researchers during the past few years. While
many groups have successfully produced cattle by nuclear transfer, and progress in this
area continues, nuclear transfer remains a very inefficient technology. This study
evaluates the effect of the oocyte source (cow and heifer) on the developmental
competence of nuclear transfer embryos. In order for nuclear transfer to be successful, a
differentiated donor cell must be reprogrammed and restored to a totipotent state. This
reprogramming is probably accomplished by factors within the oocyte cytoplasm. This
study indicates that oocytes derived from cows have a greater capacity to reprogram
donor cell DNA following nuclear transfer as compared to heifer oocytes based on in
vitro development to the 2-cell stage and to the compacted morula/blastocyst stages.
Nuclear transfer embryos derived from cow oocytes resulted in significantly higher rates
of pregnancy establishment than embryos derived from heifer oocytes and resulted in
higher pregnancy retention at 90 and 180 days and a greater number of term deliveries.
Following delivery more calves derived from cow oocytes tended to be healthy and
normal than those derived from heifer oocytes. The differences in developmental
1
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efficiency between nuclear transfer embryos derived from cow and heifer cytoplasts
demonstrate that subtle differences in oocyte biology can have significant effects on
subsequent development of nuclear transfer embryos.
Introduction
Successful somatic cell nuclear transfer (NT) has been achieved in domestic
animals and rodents as reported by the birth of offspring. The overall efficiency of this
technique, however, remains low, generally less than 2% (Hill 2002). A high frequency of
early post-implantation developmental arrest and abortion occurs, especially in cattle.
The exact mechanism(s) contributing to losses are still unclear. Epigenetic alterations
(Cezar et al. 2003; Wrenzycki et al. 2001), and chromosomal abnormalities (Burgoyne et
al. 1991; Li et al. 2004a; Li et al. 2004b) likely contribute to developmental failure.
Following the transfer of a differentiated nucleus into an enucleated MII oocyte
the nucleus is disassembled, an event involved in reprogramming the differentiated donor
nucleus to a totipotent embryonic state. This disassembly involves nuclear envelope
breakdown (NEBD) and premature chromosome condensation (PCC), mediated by high
levels of mitosis/meiosis/maturation-promoting factor (MPF) in the oocyte cytoplasm
(Barnes et al. 1993; Campbell et al. 1996; Czolowska et al. 1984). These events are
followed by erasure of epigenetic modification of DNA including changes in histone
acetylation (Nakao 2001) and DNA methylation (Kang et al. 2003; Shi et al. 2003a).
Since maternal transcripts are responsible for the events of early embryonic development
(Telford et al. 1990), nuclear reprogramming is presumably mediated by factors in the
oocyte cytoplasm.
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A number of studies have been undertaken to evaluate reprogramming
dynamics in vitro following NT. Evaluation of DNA methylation patterns in developing
NT embryos indicates demethylation and remethylation events are not always faithfully
recapitulated in the mouse (Chung et al. 2003; Mann et al. 2003; Shi and Haaf 2002) and
the cow (Bordignon et al. 2001; Dean et al. 2001; Kang et al. 2002). It is also clear that
histone acetylation is sometimes aberrant in bovine NT embryos (Enright et al. 2003).
This incomplete epigenetic reprogramming is the predominant explanation for the
frequent aberrant gene expression in NT embryos and the subsequent failures in
development (Santos et al. 2003).
Improvements in NT efficiency will require an understanding of the factors that
result in improved reprogramming. Two elements of the NT process likely have an effect
on reprogramming efficiency: the state of the donor cell/nucleus and a suitable recipient
cytoplast.
Attempts have been made to improve the efficiency of NT by manipulation of the
donor cell prior to NT. One approach is treatment of donor cells to change DNA
methylation or histone acetylation levels to more closely approximate levels found in IVF
embryos. The DNA methyl-transferase inhibitor 5-aza-2'-deoxycytidine (Aza-C) has been
utilized to reduce DNA methylation levels in the transferred nucleus, and Trichostatin A
(TSA), a histone deacetylase inhibitor has been used to increase histone acetylation
(Enright et al. 2003; Enright et al. 2005; Shi et al. 2003b). These approaches have
demonstrated reduced DNA methylation and increased histone acetylation in
preimplantation NT embryos, but no report addressing the viability of transferred
embryos exists.
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The recipient cytoplast likely has a more profound impact on the success of NT
than the donor cell simply because it makes a more significant contribution to the
reprogramming process. In the early bovine embryo rRNA is not transcribed until the 4cell stage (Viuff et al. 1998), and high transcriptional activity is not observed until the 816-cell stage (Bilodeau-Goeseels and Panich 2002; Memili et al. 1998), so events of early
embryogenesis are almost completely dependent on maternal transcripts and oocyte
proteins. Differences in developmental capacity of fetal, calf, and adult oocytes in IVF
experiments have been noted by several groups (Pujol et al. 2004; Rizos et al. 2005)
demonstrating important differences in developmental capacity depending on the source
of oocytes. The present study was designed to examine the differences in developmental
capacity in vitro and in vivo of NT embryos derived from cow versus heifer cytoplasts.
Materials and Methods
Unless otherwise noted, all reagents used were obtained from MP Biomedicals
(Irvine, CA).
Donor Cell Culture
Donor cell lines were established from nine separate animals. Five cell lines were
derived from lung tissue collected from slaughtered steers at approximately 18 months of
age. The other four cell lines were derived from ear biopsy of dairy cows greater than
three years of age. Tissues were washed thoroughly in Flush Medium; Hank’s Balanced
Salt Solution supplemented with 2% Fetal Bovine Serum (FBS) and antibiotics.
Following the wash, tissue was minced, suspended in DMEM/Ham's F12 (1:1)
supplemented with 15% FBS and antibiotics, seeded in 25 cm2 tissue culture flasks, and
cultured at 39˚C in a humidified atmosphere of 5% CO2 in air for several days. Upon
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establishment of primary tissue outgrowths, cells were harvested and used to seed
additional flasks. Primary cell lines were expanded then harvested in tissue culture
medium containing 10% DMSO and stored in liquid N2 until use in NT. Frozen/thawed
cells were grown to 80-100% confluence then passaged for use as nuclear donors. Cells
from passages 1-10 were used for NT. Donor cell type (lung and ear), cell line, and
passage number were distributed evenly across oocyte groups such that an equivalent
proportion of embryos from each cell line and passage was produced using heifer and
cow oocytes and subsequently transferred. This was done in order to avoid confounding
effects brought about by donor cell variation between groups.
Oocyte Collection and Maturation
Heifer and cow ovaries were collected from the abattoir and oocytes were
aspirated into 50-mL centrifuge tubes from 3-8 mm follicles using an 18-gauge needle
connected to a vacuum pump. Oocytes with evenly shaded cytoplasm and intact layers of
cumulus cells were selected and washed in PB1 supplemented with 3 mg/mL BSA.
Washed oocytes were then transferred into maturation medium; M199 containing 10%
fetal bovine serum (FBS; HyClone Laboratories, Logan, UT), 0.5 µg/mL FSH (Sioux
Biochemicals, Sioux City, IA), 5 µg/mL LH (Sioux Biochemicals), and 100 U/mL
penicillin/ 100 µg/mL streptomycin (HyClone Laboratories, Logan, UT) and cultured for
18-21 h prior to NT.
Nuclear Transfer
Nuclear transfer was performed according to established protocols common to
this laboratory (Li et al. 2004b; Wells et al. 1999) with the following modifications.
Briefly, enucleations were performed on matured MII bovine oocytes 18-21 h after the
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initiation of maturation. Manipulations were performed in calcium- and magnesiumfree PB1 supplemented with 3mg/ml fatty acid-free BSA and 7.5µg/ml cytochalasin B.
Fusions of NT couples were performed in mannitol fusion medium by two electric DC
pulses of 2.2 kV/cm for 30 microseconds. Fused embryos were activated at 24 h after the
onset of maturation by exposure to 5 µM ionomycin for 5 min followed by five h
incubation in cycloheximide at a concentration of 10 µg/ml.
Embryo Culture
After activation, embryos were cultured on a monolayer of bovine cumulus cells
in 50 µL drops of CR2 containing 3% FBS overlaid with mineral oil. The embryos were
cultured at 39˚ C in a humidified atmosphere of 5% CO2 in air for 7-8 days, and media
was changed and development evaluated approximately every 48 h.
Embryo Transfer
On Day 6 or 7, compacted morulae and blastocysts were shipped overnight in
equilibrated CR2 at 38.5 ˚ C to the site of transfer. One to four embryos (average 1.9)
were transferred nonsurgically to cows synchronized + 1 day to the stage of the embryos.
Equal numbers of embryos per recipient were transferred from both cow and heifer
groups.
Pregnancy Evaluation
Pregnancy was detected by trans-rectal ultrasound between days 25 and 30, and
pregnant recipients were checked by ultrasound or palpation at approximately 30-day
intervals to confirm ongoing pregnancies.
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Statistical Analysis
Data were pooled from at least 15 replicates per group for the in vitro
development studies. Chi-square analysis was used to determine differences in cleavage,
development to the compacted morula/blastocyst stages, and pregnancy establishment
and maintenance. Unless otherwise noted, a probability of P<0.05 was considered
statistically significant.
Results
NT embryos derived from cow oocytes developed to the 2-cell and compacted
morula/blasocyst stages (79.5% and 26.5%, respectively) at a higher rate than those from
heifer oocytes (59.8% and 14.8%, respectively, P<0.001; Table 2-1). Further, transferred
morulae/blastocysts produced from cow oocytes established pregnancy at a higher rate
than heifer oocyte-derived embryos, and pregnancies were retained at a higher rate at 90
and 180 days and to term (P<0.025; Table 2-2 and FIG. 2-1). The difference in pregnancy
rates at 60 days approaches significance (P<0.1) Pregnancy rates for cow oocyte-derived
embryos at were 51.3% at 25 days, 38.5% at 60 days, 28.2% at 90 days, 28.2 at 180 days,
and 25.6% at term. In contrast, pregnancy rates from heifer oocyte-derived NT embryos
were 29.2% at 25 days, 23.1% at 60 days, 7.7% at 90 days, 3.1% at 180 days, and 3.1% at
term. It is also interesting to note that the differences in pregnancy retention are not
simply the result of a higher proportion of embryos establishing pregnancy. When
pregnancy retention is evaluated based on the number of initial pregnancies established,
the difference in pregnancy retention approaches significance at 90 days when 26.3% of
initial pregnancies are ongoing in the heifer group and 55.0% of pregnancies from the
cow group were ongoing (P<0.1) The difference is significant (P<0.01) at 180 days
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(10.5% for heifer and 55.0% for cow) and at term (10.5% for heifer and 50.0% for
cow). At birth nine of the ten calves derived from cow oocytes were apparently normal
and healthy while in the heifer group only one of the two calves that reached term was
healthy. This difference approaches significance at P<0.20.
Table 2-1. In vitro development of NT embryos derived from cow and heifer
cytoplasts.
Oocyte source
Heifer
Cow

No. Fused
1746
479

No. Cleaved (%)a
1044 (59.8)a
381 (79.5)b

No. Compacted Morulae/Blastocysts (%)a
259 (14.8)a
127 (26.5)b

Values with different superscripts within each column are different (P<0.001).
a
Percentage of fused embryos.

Table 2-2. Rates of pregnancy establishment and retention throughout gestation of
NT embryos derived from cow and heifer cytoplasts.
Pregnancies
25 days (%)a 60 days (%)a 90 days (%)a
Oocyte Total
Transfers
Source
Heifer
65
19 (29.2)a
15 (23.1)
5 (7.7)a
Cow
39
20 (51.3)b
15 (38.5)
11 (28.2)b

180 days (%)a Term (%)a Healthy at
birth (%)b
a
a
2 (3.1)
2 (3.1) 1 (50.0)
b
11 (28.2)
10 (25.6)b 9 (90.0)

Values with different superscripts within each column are different (P<0.025)
a
Percentage of total transfers.
b
Percentage of term calves.
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Figure 2-1. Pregnancy rates throughout gestation following transfer of NT embryos
derived from cow and heifer cytoplasts.
a, b
Values with different superscripts within each column are different (P<0.025).
Discussion
These data indicate that there are important differences between cow and heifer
oocytes which make cow oocytes more suitable for use in bovine NT. Understanding the
differences between cow and heifer oocytes and how those differences affect the
efficiency of development following NT is an important step in improving the reliability
of the process. Little research has been done to evaluate these differences, however it has
been well established that calf oocytes differ from cow oocytes, and embryos derived
from calf oocytes following IVF are less developmentally competent than IVF embryos
derived from cow oocytes (Damiani et al. 1996; de Paz et al. 2001; Gandolfi et al. 1998;
Khatir et al. 1998; Levesque and Sirard 1994; Majerus et al. 2000; Revel et al. 1995;
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Salamone et al. 2001). These studies may offer insights into potential differences
between cow and heifer oocytes.
Studies of pre-pubertal calf oocytes have indicated they differ from cow oocytes
in several important ways. It has been demonstrated that IVF embryos derived from calf
oocytes develop slower in vitro, arrest more frequently at the 9-cell stage, and exhibit a
longer lag phase before maternal to zygotic transition (Majerus et al. 2000). Calf oocytes
also undergo nuclear maturation at a slower rate than cow oocytes (Khatir et al. 1998).
Gandolfi et al. reported that calf oocytes are smaller in diameter, metabolize glutamine
and pyruvate at a lower rate during the first three h of IVM, and exhibit a decline in
protein synthesis earlier as compared with cow oocytes (Gandolfi et al. 1998). Other
groups have also reported different patterns of protein synthesis between cow and calf
oocytes (Gandolfi et al. 1998; Levesque and Sirard 1994; Salamone et al. 2001). Calf
oocytes contain more microvilli on their cell surface and more endocytic vesicles than
cow oocytes, while cow oocytes contain a larger superior mitochondrial population than
calf oocytes (de Paz et al. 2001). Numerous reports have indicated that fewer calf oocytes
develop to blastocyst as compared with cow oocytes in IVF, parthenogenetic, and NT
experiments (Damiani et al. 1996; Levesque and Sirard 1994; Majerus et al. 2000; Revel
et al. 1995; Salamone et al. 2001). Additional work by Revel et al. indicated that a much
lower pregnancy rate results from the transfer of blastocysts derived from calf oocytes (1
of 23 recipients; 4%) compared with cow-oocyte-derived blastocysts (10 of 26 recipients;
38%). The single pregnancy established from calf embryos resulted in a full-term live
calf (Revel et al. 1995). This indicates that although the overall developmental
competence of calf oocytes is much lower, some oocytes derived from pre-pubertal
animals do have the capacity to direct development to term.
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While many studies have evaluated the differences in developmental
competence between cow and pre-pubertal calf oocytes fertilized in vitro, less attention
has been given to potential differences between cow and heifer oocytes. There are several
reports of differences between cow and heifer oocytes in terms of numbers of oocytes per
ovary and in vitro developmental efficiency. Researchers have reported fewer oocytes
collected from cows than from heifers following slaughter (Moreno et al. 1992) and also
in conjunction with ovum pick up (Rizos et al. 2005). Rizos et al. also compared the
number and quality of oocytes from slaughtered crossbred beef heifers under thirty
months and cows over four years old (Rizos et al. 2005). They found no differences in the
number of oocytes collected per ovary, however following IVF significantly more cow
oocytes developed to blastocyst on day 8 as compared to heifer oocytes (46.5% and
33.4% respectively). In their experiment heifer oocytes were further divided into groups
based on the age of the donor (12-18 months, 19-24 months, and 25-30 months). There
was no difference in blastocyst development between the three age groups (35.0%,
35.2%, and 36.5%, respectively) The superiority of cow oocytes over heifer oocytes in
terms of development to blastocyst (27.5% and 16.4%, respectively) was also reported by
Zhang et al. (Zhang et al. 1991). Mermillod et al. evaluated the developmental potential
of oocytes collected from cows of different ages and found no significant difference in
blastocyst yield between oocytes from 1-3 year old cows compared with oocytes from
cows older than three years old (Mermillod et al. 1992). A study involving the collection
of oocytes from a slaughtered, Bovine Spongiform Encephalopathy (BSE)-infected herd
also compared rates of development to blastocyst of oocytes collected from heifers and
cows. Cow oocytes developed to grade-one blastocysts at a slightly higher rate than
heifer oocytes (14.6% and 10.2%, respectively) however the difference was not
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significant (Galli et al. 2003). We are not aware of any study evaluating the quality of
NT embryos derived from cow and heifer oocytes following transfer.
In addition to the scarcity of research evaluating the developmental competence
of heifer oocytes, very little research has been done to evaluate the effect of oocyte
source on bovine NT. Two studies have evaluated the developmental competence of calf
oocytes used in NT. Both reported lower rates of development to the 2-cell stage and to
blastocyst compared with development using cow oocytes. In one study, cleavage of NT
embryos was 75% with cow oocytes and 69% with calf oocytes, and blastocyst
development was 21% and 9%, respectively (Mermillod et al. 1998). A second study
reported cleavage rates of 67% and 22% and blastocyst rates of 20% and 5% using cow
and calf oocytes, respectively (Salamone et al. 2001).
Similar to the data from NT studies using calf oocytes, the present study indicates
that cow oocytes are superior to heifer oocytes in directing development of NT couplets
in vitro. In vitro development to transferable compacted morula/blastocyst stage between
the two groups differs significantly [Table 1 (14.8% for heifer and 26.5% for cow)], and
the differences are further amplified following transfer to recipients (Table 2-2 and FIG.
2-1). The development of heifer oocyte-derived NT embryos to blastocyst offers evidence
that in vitro development alone is not a reliable indicator of overall embryo quality.
While it is clear that in vitro development is not the best indicator, often it is not feasible
to transfer embryos to evaluate quality. More reliable and efficient measures of embryo
quality must be developed to assist in pre-transfer selection of NT embryos with high
developmental competence.
In the environment of the recipient cytoplast following NT, the donor nucleus
undergoes dramatic changes that result in the restoration of totipotency to a differentiated
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nucleus in a process referred to as nuclear reprogramming. Events similar to those that
occur during reprogramming of the donor cell can be observed in sperm and oocyte DNA
following fertilization. Prior to fertilization, sperm and oocyte genomes are much more
highly methylated than somatic cells (Obata et al. 1998). At fertilization, sperm
chromatin is actively demethylated, possibly by direct removal of the methyl group from
the cytosine (Bhattacharya et al. 1999) or by exchange of the 5-methylcytosine with
unmethylated cytosine via base excision (Weiss et al. 1996). The maternal genome is also
demethylated during early development, but in a passive, replication-dependent manner.
This global demethylation is subsequently followed by de novo methylation of the
genome starting at the 8-cell stage in bovine embryos and the blastocyst stage in mice
resulting in differentiation of cell lineages during development (Reik et al. 2001).
The same machinery that is involved in chromatin modifications following
fertilization is likely recruited for reprogramming of the donor nucleus following NT.
Nuclear reprogramming of the donor cell following NT involves nuclear envelope
breakdown (NEBD) and premature chromosome condensation (PCC; Barnes et al. 1993;
Campbell et al. 1996; Czolowska et al. 1984), followed by erasure of epigenetic
modifications to DNA including changes in histone acetylation (Nakao 2001) and DNA
methylation (Kang et al. 2003; Shi et al. 2003b). Since maternal transcripts are
responsible for the events of early embryonic development (Telford et al. 1990), and
given the events that occur naturally following fertilization, nuclear reprogramming is
likely mediated by factors in the oocyte cytoplasm. The results of this study demonstrate
the profound impact differences in the source of the oocyte can have on development of
bovine NT embryos in vitro and in vivo.
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The improved efficiency in NT using cow oocytes reflects more efficient
reprogramming of the donor nucleus, which leads to slightly improved development in
vitro and higher rates of pregnancy establishment and retention throughout gestation.
Determining the inherent differences between cow and heifer oocytes will offer insights
into transcripts or proteins that are potentially important in the process of nuclear
reprogramming.
Conclusion
These data demonstrate that when possible cow oocytes should be utilized for
bovine NT experiments over heifer oocytes. The present study also indicates that heifer
oocytes are capable of reprogramming donor nuclei and producing live NT offspring,
albeit at a much lower rate. Understanding the molecular and physiological differences
between cow and heifer oocytes will provide valuable insights into factors that are
important in nuclear reprogramming. This could open doors to improvements in oocyte
selection or maturation parameters and ultimately result in improved efficiency in the
currently very inefficient process of bovine NT.
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CHAPTER 3
EFFECT OF THE TIME INTERVAL BETWEEN FUSION AND ACTIVATION
ON NUCLEAR STATE AND DEVELOPMENT IN VITRO AND IN VIVO OF
BOVINE SOMATIC CELL NUCLEAR TRANSFER EMBRYOS
Abstract
This study indicated that prolonged exposure of donor cell nuclei to oocyte
cytoplasm prior to activation resulted in abnormal chromatin morphology, and reduced
development to compacted morula/blastocyst stages in vitro, however following transfer
of embryos to recipients there was no difference in pregnancy rates throughout gestation.
Chromatin morphology was evaluated for embryos held 2.0, 3.0, 4.0, and 5.0 h between
fusion and activation. In embryos held 2.0 h, 15/17 (88.2%) embryos contained
condensed chromosomes, while only 12/24 (50.0%) embryos held 3.0 h exhibited this
characteristic. The proportion of embryos with elongated or fragmented chromosomes
tended to increase with increased hold time. While 15/19 (78.9%) of embryos held 2.0 h
developed a single pronucleus 6 h after activation, only 8/22 (36.4%) had 1 pronucleus
after a 4.0 h hold. Embryos held 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0 h cleaved at rates of
207/281 (73.7%), 142/166 (85.5%), 655/912 (71.8%), 212/368 (57.6%), 406/667
(60.9%), 362/644 (56.2%), and 120/228 (52.6%) respectively. Further development to
compacted morula/blastocyst stage occurred at rates of 78/281 (27.8%), 42/166 (25.3%),
264/912 (28.9%), 79/368 (21.5%), 99/667 (14.8%), 94/644 (14.6%), and 27/228 (11.8%)
respectively. Embryos held <2.5 h between fusion and activation established pregnancies
in 18/66 (27.3%) of recipients, while embryos held >2.5 h established pregnancies at a
rate of 17/57 (29.8%). This study indicates holding bovine nuclear transfer embryos <2.5
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h between fusion and activation results in improved nuclear morphology and increased
development to compacted morula/blastocyst, and results in pregnancy rates equivalent to
embryos held >2.5 h.
Introduction
Successful somatic cell nuclear transfer (NT) has been achieved in domestic
animals and rodents as reported by the birth of offspring. The overall efficiency of this
technique, however, remains low, generally less than 2% (Hill 2002). A high frequency of
early post-implantation developmental arrest and abortion occurs, especially in cattle.
The exact mechanism(s) contributing to losses are still unclear. Epigenetic alterations
(Cezar et al. 2003; Wrenzycki et al. 2001), and chromosomal abnormalities (Burgoyne et
al. 1991; Li et al. 2004a; Li et al. 2004b) likely contribute to developmental failure.
Following the transfer of a differentiated nucleus into an enucleated MII oocyte,
the nucleus is disassembled, an event involved in reprogramming the differentiated donor
nucleus to a totipotent embryonic state. This disassembly involves nuclear envelope
breakdown (NEBD) and premature chromosome condensation (PCC), mediated by high
levels of mitosis/meiosis/maturation-promoting factor (MPF) in the oocyte cytoplasm
(Barnes et al. 1993; Campbell et al. 1996; Czolowska et al. 1984). These events are
followed by erasure of epigenetic modification of DNA including changes in histone
acetylation (Nakao 2001) and DNA methylation (Kang et al. 2003; Shi et al. 2003). Since
maternal transcripts are responsible for the events of early embryonic development
(Telford et al. 1990), nuclear reprogramming is presumably mediated by factors in the
oocyte cytoplasm.
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Several groups have shown that the duration of exposure of the donor nucleus
to oocyte cytoplasm following NT affects in vitro development, however the conclusions
are mixed. Some reports have indicated a prolonged exposure to the oocyte cytoplasm
prior to activation may be beneficial in promoting embryo development for bovine (Wells
et al. 1999; Wells et al. 1998) and murine NT (Wakayama et al. 1998). Another study
reported the exposure of transferred nuclei to cytoplasm for less than 30 min prior to
activation yielded significantly lower blastocyst development than a 2-h exposure (Liu et
al. 2001). Conversely, other research indicates excessive exposure of the donor DNA to
oocyte cytoplasm results in lower rates of in vitro development in cloned embryos (Akagi
et al. 2001). Most recently, Choi et al. demonstrated that in vitro development of bovine
NT embryos to blastocyst decreased as time in hold was increased from 1 to 5 h (Choi et
al. 2004).
Given the conflicting data on the subject we have evaluated the effect of timing
between fusion and activation on NT development. The present study was designed to
examine the effect of different time intervals between fusion and activation on structure
of the transferred nucleus and embryonic development in vitro and in vivo.
Materials and Methods
Unless otherwise noted, all reagents used were obtained from ICN Biochemicals.
Donor cell culture
Primary bovine fibroblast cultures were established from either lung tissue or ear
biopsy. Previous data have demonstrated no difference in in vitro development between
lung- and ear-derived donor cells (Kato et al. 2000). Tissues were washed thoroughly and
minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone Laboratories, Logan, UT)
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supplemented with 15% fetal bovine serum (FBS; HyClone Laboratories, Logan, UT)
and 100 U/mL penicillin/ 100 µg/mL streptomycin (HyClone Laboratories), seeded in 25
cm2 tissue culture flasks, and cultured at 39˚C in a humidified atmosphere of 5% CO2 in
air for several days. Cells were then harvested in tissue culture medium containing 10%
DMSO and stored in liquid N2 until use in NT. Frozen/thawed cells were grown to 80100% confluence and passages 2-16 were used as nuclear donors.
Oocyte Maturation
Maturation of bovine oocytes was performed as described previously (Li et al.
2004a; Li et al. 2004b). Briefly, cumulus oocyte complexes (COC) were aspirated from
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.
Only those with uniform cytoplasm and intact layers of cumulus cells were selected and
matured in TCM 199 containing 10% FBS, 0.5 µg/mL FSH (Sioux Biochemicals, Sioux
City, IA), 5 µg/mL LH (Sioux Biochemicals), and 100 U/mL penicillin/ 100 µg/mL
streptomycin for 18-22 h.
Nuclear Transfer
Following maturation, cumulus cells were removed by vortexing COC in PB1
(calcium and magnesium containing phosphate buffered saline [HyClone Laboratories,
Logan, UT], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/mL BSA) medium
containing 10 mg/mL hyaluronidase. Oocytes with a first polar body were used as
recipient cytoplasts. Enucleation was employed to remove the first polar body and
metaphase plate, and single cells were subsequently transferred to the perivitelline space
of recipient cytoplasts. Fusions of NT couplets were performed in mannitol fusion
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medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25
microseconds. Following fusion, embryos were held in CR2 medium supplemented with
3% FBS for 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0 h prior to activation. Fused embryos were
activated between 23 and 25 h after the onset of maturation by exposure to 5 µM
ionomycin for 5 min followed by five h incubation in 10µg/ml cycloheximide.
Nuclear and Microtubule Assessment
by Immunofluorescent Staining
Reconstructed embryos were fixed 2.0, 3.0, 4.0, and 5.0 h after fusion. Some
embryos activated 2.0 and 4.0 h after fusion were fixed 6.0 h after initial activation to
evaluate pronuclear morphology. Immunofluorescent staining was performed as reported
(Zhu et al. 2003) with some modifications. Briefly, embryos were fixed with 3.7% (w/v)
paraformaldehyde in PBS overnight at 4°C. Fixed embryos were extracted in PBS
containing 1% (w/v) Triton X-100 and 0.3% BSA for 1.0 h at 37°C. After two washes
with PBS containing 0.01% Triton X-100, embryos were blocked in PBS containing 150
mM glycine and 1% Triton X-100 for 1.0 h at 37°C. The embryos were then incubated
for 1.0 h at 37°C in a mouse monoclonal antibody against α-tubulin (Sigma, T-5168)
diluted 1:100 in PBS. They were then washed with PBS and incubated in fluorescein
isothiocyanate-labeled goat-anti-mouse IgG (Southern Biotechnology Associate, Inc.
Birmingham, AL 35226. Cat No. 1030-02) diluted 1:100 in PBS for 1.0 h at 37°C.
Chromatin was stained with 10 µg/ml of propidium iodide. Finally, embryos were
mounted on slides with a solution of glycerol and PBS (1:1). The samples were examined
under a Zeiss epifluorescent microscope (Carl Zeiss Optical, Inc., Chester, Virginia,
USA). Images were captured by digital camera with the PIXERA Viewfinder Program
(Pixera Corporation, Los Gatos, California, USA).
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Embryo Culture
After activation, embryos were cultured under mineral oil in 50 µL droplets of
CR2 with 3% FBS on a monolayer of bovine cumulus cells at 39°C in an atmosphere of
5% CO2 in air for 6-7 days. Medium was changed every 48 h. Cleavage and compacted
morula/blastocyst rates were recorded 48 h and 6-7 days post-activation, respectively.
Embryo Transfer
On Day 6 or 7, compacted morulae and blastocysts were shipped overnight in
equilibrated CR2 at 38.5 ˚ C to the site of transfer. One to two embryos were transferred
nonsurgically to cows synchronized + 1 day to the stage of embryonic development.
Pregnancy was detected by trans-rectal ultrasound at embryonic d 25-30.
Statistical Analyses
Data were pooled from at least four replicates per group for the in vitro
development studies. Chi-square analysis was used to determine differences in cleavage
and development to the compacted morula stage between hold times. Differences in
remodeling and nuclear morphology between groups were analyzed using Student's t-test.
Unless otherwise noted, a probability of P<0.05 was considered statistically significant.
Results
Nuclear Morphology
When the pre-activation reconstructed embryos were examined 2.0 h after fusion
the majority of the embryos (88%, 15/17) possessed condensed chromosomes (Fig. 3-1a)
or a chromosome array resembling the maternal metaphase plate (metaphase-like
chromosomes, Fig. 3-1b), which was significantly higher (P<0.05) than embryos
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examined 3 h after fusion (50%, 12/24). The proportion of the embryos possessing
elongated or scattered chromosomes tended to increase with increasing time between
fusion and activation (Table 3-1). Eighty-two percent of the embryos held 4.0 to 5.0 h
between fusion and activation possessed elongated (Fig. 3-1c, d) or scattered (Fig. 3-1e)
chromosomes.
Table 3-1. Remodeling of transferred bovine somatic cells at various times after
fusion.
Time after fusion (h)
2

No. embryos
examined
17

3

24

4
5

Nuclear remodeling types (%)
Condensed Chr. Metaphase-like Elongated Chr.
9 (52.9)a
6 (35.3)b
2 (11.8)c
2 (8.3)c

Scattered. Chr.

PN

10 (41.7)a

9 (37.5)b

3 (12.5)b

25

2 (8)c

12 (48)a

9 (36)a

2 (8)

25

2 (8)c

9 (36)b

11(44)a

3 (12)

a,b,c

Values with different superscripts in the same column differ from each other at
P<0.05.

Of embryos observed 6.0 h after activation, 78.9% of the embryos activated 2.0 h
after fusion developed a single pronuclear structure (PN), which was significantly higher
than those activated 4.0 h after fusion (36.4%; Table 3-2). Of the embryos activated 4.0 h
after fusion 63.6% possessed 2 or more PN (Fig. 3-1f-i).
Table 3-2. Nuclear morphology of bovine NT embryos 6 h after activation.
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Activation time post-fusion (h)
2

No. embryos
examined
19

4

22

a, b

Pronucleus (PN) status (%)
1PN
2PN
15 (78.9)a
3 (15.8)
8 (36.4)b

4 (18.2)

3PN
1 (5.3)

4-8 PN
0

2 (9.0)

6 (27.3)

Scattered Chr.
0
2 (9.0)

Values with different superscripts in the same column differ from each other at P<0.05.

Figure 3-1. Nuclear remodeling and morphology of bovine nuclear transferred
embryos. A-E, remodeling of nuclei after fusion. A. Condensed chromosomes, small
microtubule aster existed among chromatin; B, metaphase-like chromosomes with
strongly stained microtubules; C and D, elongated chromosomes and microtubules
connecting the chromosomes; E, scattered chromosomes. From F to I, the representatives
of 1 PN, 2 PN, 3 PN, 7 PN, respectively, after activation of fused nuclear transferred
embryos. Bars represent 10µm.
Embryo Development In Vitro and In Vivo
Cleavage of embryos derived from groups activated 1.0-2.0 h after fusion (71.8%85.5%) was significantly higher (P<0.01) than embryos held 2.5-4.0 h between fusion
and activation (52.6%-60.9%; Fig. 3-2 & Table 3-3). The compacted morula/blastocyst
development of embryos activated 1.0-2.5 h post fusion (21.5%-28.9%) was higher
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(P<0.01) than embryos activated after 3.0-4.0 h post fusion (11.8%-14.8%; Fig. 3-2 &
Table 3-3). Following transfer of the cloned compacted morulae/blastocysts to recipients
no differences were observed in d 30 pregnancy rates between embryos held <2.5 h (18
pregnancies/66 transfers (27.3%)) and embryos held >2.5 h (17 pregnancies/57 transfers
(29.8%)). Pregnancy retention was evaluated around days 60, 90, 180, and term, and no
differences in pregnancy retention were observed at any stage of gestation with 3 calves
being born in the <2.5 h group and 1 calf being born in the >2.5 h group.

9 0 .0 %
b

8 0 .0 %
a

a

7 0 .0 %
c
6 0 .0 %

c

c
c

1 .0
1 .5
2 .0
2 .5
3 .0
3 .5
4 .0

5 0 .0 %

4 0 .0 %
a
b

3 0 .0 %

a
b

h
h
h
h
h
h
h

a

b
2 0 .0 %
c

c
c

1 0 .0 %

0 .0 %
% c lea v ed

% c o m p a c te d m o ru la e /b la s to c ys ts

Figure 3-2. In vitro development of bovine NT embryos based on time between
fusion and activation.
a, b, c
Values with different superscripts in the same group differ from each other at P<0.01.
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Table 3-3. In vitro development of bovine NT embryos with different hold times.
Time in hold (h)
1.0

No. cultured
281

No. cleaved (%)

No. compacted morulae/blastocysts (%)

b

78 (27.7)ab

a

207 (73.7)

1.5

166

142 (85.5)

42 (25.3)ab

2.0

912

655 (71.8)b

264 (28.9)a

368

c

79 (21.5)b

c

2.5

212 (57.6)

3.0

667

406 (60.9)

99 (14.8)c

3.5

644

362 (56.2)c

94 (14.6)c

228

c

27 (11.8)c

4.0

120 (52.6)

a, b, c

Values with different superscripts in the same column differ from each other at
P<0.01.
Discussion
In order for NT to be successful the donor nucleus must be properly
reprogrammed. During nuclear reprogramming epigenetic marks are erased from the
donor nucleus genome, resulting in an erasure of tissue-specific gene expression patterns

and effectively resetting the cell to a totipotent state (Santos and Dean 2004). Our studies
indicate that timing between fusion and activation probably has a critical impact on
reprogramming.
Studies evaluating DNA methylation patterns in developing NT embryos indicate
demethylation and re-methylation events are not always faithfully recapitulated in the
mouse (Chung et al. 2003; Mann et al. 2003; Shi and Haaf 2002) and the cow (Bourc'his
et al. 2001; Dean et al. 2001; Kang et al. 2002). It is also clear that histone acetylation is
sometimes aberrant in bovine NT embryos (Santos et al. 2003). This incomplete
epigenetic reprogramming is the predominant explanation for the frequent aberrant gene
expression in NT embryos and the subsequent failures in development (Santos et al.
2003).
The mechanisms responsible for DNA demethylation may follow a pattern of
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activity similar to MPF with high activity prior to activation and a diminishing of
activity following activation. Further research will be required to determine those
dynamics, but based on the study by Dean et al. there appears to be a critical window of
time in which active demethylation can occur following fusion (Dean et al. 2001). The
idea of this critical window between fusion and activation is supported by the work of
Bourc'his et al. in which active demethylation was not observed when activation was
performed at the time of fusion (Bourc'his et al. 2001).
Nuclear remodeling is an important element in the process of reprogramming that
must occur in NT embryos. Our research as well as the research of others has
demonstrated that chromatin remodeling and blastomere ploidy frequently deviates from
normal following NT in various species including cattle (Booth et al. 2003; Bureau et al.
2003; Li et al. 2004a; Li et al. 2004b) rabbits (Shi et al. 2004), and pigs (Kim et al. 2005).
Several significant morphological changes occur in the donor nucleus following NT into
cytoplasts with high MPF activity. These changes include nuclear envelope breakdown
(NEBD) and premature chromosome condensation (PCC) (Campbell et al. 1996;
Czolowska et al. 1984). Following these two events, the nuclear envelope is re-formed,
and DNA synthesis commences (Campbell et al. 1993). Aberrations or deficiencies in
these events might result in some of the problems associated with early development in
NT embryos.
Figures 3-1-C and 3-1-D show elongated chromosome sets. It is clear how these
cells might end up with 2-3 PN (as in Figures 3-1-G and 3-1-H) following activation as
areas where microtubules are thinner are likely more prone to depolymerization and
fragmentation. This is supported by the fact that more elongated chromosome sets were
observed with increased time after fusion and more embryos displayed multiple PN when
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held four h between fusion and activation as compared with embryos activated two h
after fusion. Likewise, a scattered chromosome arrangement as observed in Figure 3-1-E
would result in multiple PN following activation. It is also probable that those embryos
with more than one PN following activation will result in nuclear fragmentation and
unbalanced chromosome constitutions.
The amount of time the donor nucleus is exposed to oocyte cytoplasm prior to
activation is critical in subsequent development of NT embryos. Based on our data, it
appears that prolonged exposure to arrested MII oocyte cytoplasm results in more
frequent structural abnormalities in nuclear material, manifesting itself as elongated
chromatin prior to activation and the development of multiple pronuclei following
activation.
While it is important to note that the number of morphologically “normal”
embryos prior to activation (embryos with compacted or metaphase-like chromosomes)
and following activation (single PN) declines when embryos are held longer than 3.0 h
prior to activation, it is also noteworthy that some embryos held longer do appear normal
and develop to compacted morula/blastocyt. Our data also indicate that those embryos
that develop to compacted morula have an equal probability of establishing and
maintaining pregnancy regardless of hold time, indicating that most embryos negatively
affected by a prolonged hold time will stop developing prior to reaching compacted
morula stage.
This study evaluated the effect of the duration of exposure of the donor nucleus to
MII oocyte cytoplasm prior to activation on nuclear structure, in vitro development, and
pregnancy rates post-transfer. The data indicate that prolonged exposure to oocyte
cytoplasm results in more embryos with elongated or scattered chromosomes prior to
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activation as well as fewer embryos developing a single PN 6.0 h after activation. We
found that a hold between 1.0 and 2.0 h results in higher in vitro development and lower
rates of nuclear fragmentation. While in vitro development declines and fragmentation
increases with increased hold time, those embryos that develop to compacted morula or
blastocyst are equally likely to establish pregnancy following transfer. Based on this data,
embryos that are chromosomally compromised probably cease development prior to
reaching compacted morula stage. The data further indicates that 1 h between fusion and
activation provides the donor nucleus with sufficient exposure to MII cytoplasm to
initiate critical reprogramming events and that longer than 2 h results in reduced viability
of embryos in vitro.
The process of nuclear reprogramming during NT is extremely complex and, as
yet, not well understood. There are undoubtedly numerous proteins involved in the
process of de-differentiation that occurs in NT. Even under conditions where proper
chromosomal composition is maintained NT efficiency is still quite low. This indicates
that while compromised chromosomal composition is a factor that reduces NT efficiency,
improper epigenetic reprogramming of the donor nucleus probably has a greater impact
on NT efficiency. Further research evaluating the molecular machinery involved in
nuclear reprogramming prior to and following activation will pave the way to a better
understanding of the mechanisms of nuclear reprogramming and the development of new
strategies to improve the efficiency of the process.
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CHAPTER 4
GLOBAL GENE EXPRESSION ANALYSIS OF BOVINE SOMATIC
CELL NUCLEAR TRANSFER BLASTOCYSTS
AND COTYLEDONS
Abstract
Low developmental competence of bovine somatic cell nuclear transfer (SCNT)
embryos is a universal problem. Abnormal placentation has been commonly reported in
SCNT pregnancies from a number of species. The present study employed Affymetrix
bovine expression microarrays to examine global gene expression patterns of SCNT and
in vivo produced (AI) blastocysts as well as cotyledons from day-70 SCNT and AI
pregnancies. SCNT and AI embryos and cotyledons were analyzed for differential
expression. Also in an attempt to establish a link between abnormal gene expression
patterns in early embryos and cotyledons, differentially expressed genes were compared
between the two studies. Microarray analysis yielded a list of 28 genes differentially
expressed between SCNT and AI blastocysts and 19 differentially expressed cotyledon
genes. None of the differentially expressed genes were common to both groups, although
major histocompatibility complex I (MHCI) was significant in the embryo data and
approached significance in the cotyledon data. This is the first study to report global gene
expression patterns in bovine AI and SCNT cotyledons. The embryonic gene expression
data reported here adds to a growing body of data that indicates the common occurrence
of aberrant gene expression in early SCNT embryos.
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Introduction
The inefficiency associated with bovine SCNT has greatly limited its utility in a
number of applications including production agriculture, conservation biology, and biopharmaceutical research. While it is difficult to ascertain the overall efficiencies due to
differences in protocols, embryo transfer criteria, and data presentation the overall
efficiency of SCNT across species based on the number of embryos produced is less than
5% (Campbell et al. 2005). In cattle, approximately 10-15% of SCNT embryos
transferred develop to term (Oback and Wells 2007).
A growing amount of data indicates the inefficiencies associated with SCNT
largely result from deficiencies in nuclear reprogramming of the somatic nucleus
following NT. Following the transfer of a differentiated cell or nucleus into an enucleated
oocyte, the DNA must be reprogrammed from a cell-type-specific gene expression
pattern to a totipotent embryonic-cell state. Modifications to the epigenetic order of the
DNA are required in order for this to occur.
The oocyte is well equipped to direct the nuclear reprogramming following
normal fertilization, but less efficient at reprogramming somatic cells following SCNT.
At fertilization, sperm chromatin is actively demethylated, and the maternal genome is
demethylated in a passive, replication-dependent manner. This global demethylation is
subsequently followed by de novo methylation of the genome starting at the 8- to 16-cell
stage in bovine embryos and the blastocyst stage in the murine resulting in differentiation
of cell lineages during development (Reik et al. 2001). Histone modifications are altered
in a similar fashion following fertilization (Dean et al. 2003). A recent study analyzed the
involvement of twenty-four chromatin factors (CFs) including transcription factors and
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nuclear binding proteins in reprogramming following fertilization in the mouse.
Shortly after fertilization nearly all CFs were removed from chromatin, and shortly after
pronuclear formation CFs are re-established on the chromatin in what is described as an
“erase-and-rebuild strategy” (Sun et al. 2007).
A growing body of evidence supports the idea that SCNT inefficiency is a result
of incomplete nuclear reprogramming. Differences in gene expression of embryos
(Daniels et al. 2000; Han et al. 2003; Li et al. 2006; Santos et al. 2003) and fetuses (Hill
et al. 2002; Schrader et al. 2003), as well as aberrant DNA methylation (Kang et al. 2001;
Kang et al. 2002; Kang et al. 2003; Mann et al. 2003; Shi and Haaf 2002; Young and
Beaujean 2004) and histone acetylation (Enright et al. 2003; Enright et al. 2005; Santos et
al. 2003) in embryos and fetuses have all been reported previously. A follow-up study on
the involvement of CFs on nuclear reprogramming evaluated the dynamics of the same
CFs following SCNT and found similar patterns of CF removal and re-establishment in
the somatic nucleus, but with some differences associated with timing and efficiency. In
the case of control embryos, early development was characterized by a nearly complete
removal of CFs from the DNA and export from the nucleus followed by sequential reestablishment of the CFs. In SCNT embryos, even after removal of the majority of CFs,
some remained associated with DNA throughout early development, an indication of
incomplete reprogramming (Gao et al. 2007). Epigenetic changes associated with
differentiation of somatic cells likely make them more difficult to reprogram following
SCNT.
A common phenotypic problem with bovine SCNT pregnancies is abnormal
placentation. SCNT pregnancies are often noted to have larger and fewer placentomes
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than controls (Constant et al. 2006; Heyman et al. 2002; Hill et al. 1999; Hoffert et al.
2005; Oishi et al. 2006). Deficiencies in fetal-maternal nutrient and waste exchange
contribute to the high rates of pregnancy failure and post-partum loss (Constant et al.
2006; Heyman et al. 2002; Hill et al. 2000; Hill et al. 1999).
Based on the growing amount of data implicating deficient nuclear
reprogramming in many of the problems associated with SCNT, along with the apparent
involvement of abnormal placentation in SCNT pregnancy loss, we conducted a series of
experiments to evaluate global gene expression patterns in SCNT and AI blastocysts and
cotyledons, the fetal contribution to the placentome.
Materials and Methods
Donor Cell Culture
Primary bovine fibroblast cultures were established from lung tissue. Tissues
were washed thoroughly and minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone
Laboratories, Logan, UT 84321) supplemented with 15% fetal bovine serum (FBS;
HyClone Laboratories) and 100 U/ml penicillin/ 100 µg/ml streptomycin (HyClone
Laboratories), seeded in 25 cm2 tissue culture flasks, and cultured at 39˚C in a humidified
atmosphere of 5% CO2 in air for several days. Cells between passages one and four were
then harvested and re-suspended in tissue culture medium containing 10% DMSO,
frozen, and stored in liquid N2 until use in SCNT. Prior to SCNT, cells were thawed and
grown to 80-100% confluence. Cells were treated with trypsin (.25%) and resuspended in
manipulation medium for use in SCNT.
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Oocyte Maturation
Maturation of bovine oocytes was performed as described previously (Li et al.
2004a; Li et al. 2004b). Briefly, cumulus oocyte complexes (COC) were aspirated from
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.
Only those oocytes with uniform cytoplasm and intact layers of cumulus cells were
selected and matured in TCM 199 containing 10% FBS, 0.5 µg/ml FSH (Sioux
Biochemicals, Sioux City, IA 51250), 5 µg/ml LH (Sioux Biochemicals), and 100 U/ml
penicillin/ 100 µg/ml streptomycin for 18-22 h.
SCNT Embryo Production
Following maturation, cumulus cells were removed from oocytes by vortexing
COC in PB1 (calcium and magnesium containing phosphate buffered saline [HyClone
Laboratories], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/ml BSA) medium
containing 10 mg/ml hyaluronidase. Oocytes with a first polar body were used as
recipient cytoplasts. Enucleation was employed to remove the first polar body and
metaphase plate, and single cells were subsequently transferred to the perivitelline space
of recipient cytoplasts. Fusions of NT couplets were performed in mannitol fusion
medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25 microseconds.
Following fusion, embryos were held in CR2 medium supplemented with 3% FBS for 12 h prior to activation (Rosenkrans and First 1994). Fused embryos were activated
between 23 and 25 h after the onset of maturation by exposure to 5 µM ionomycin for 5
min followed by five h incubation in 10µg/ml cycloheximide. For the purposes of the
microarray experiments we produced three groups of ten grade 1-2 blastocysts from a
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single cell line. For real-time PCR (Q-PCR) validation, an additional three groups of
five embryos were produced. Embryos were placed in RNAlater RNA stabilization
reagent (Ambion Inc., Austin, TX 78744) and stored at -20° C until RNA extraction.
AI Embryo Production
Control embryos for microarray studies were collected from super-ovulated cows
using established protocols. Donor cows were synchronized using the EAZI-BREED™
CIDR® vaginal progesterone implant. The CIDR was used for 10 days followed by an
I.M. injection of 50 mg Lutalyse (5ml at 10 mg/ml). Animals were bred by artificial
insemination (AI) the morning following standing heat and again 12 and 24 h after
standing heat. Seven days after the initial breeding, embryos were collected from donor
animals by intra-uterine flush using embryo filters. Following collection, embryos were
rinsed in flush medium, placed in RNAlater (Ambion Inc.) and stored at -20° C until
RNA extraction. Three groups of ten grade 1 and 2 blastocysts were collected for the
microarray studies, and an additional three groups of five embryos were collected for QPCR validation.
Cotyledon Collection
Control pregnancies were established by artificial insemination of CIDRsynchronized cows, and SCNT pregnancies were established by non-surgical embryo
transfer of day 7-8 SCNT blastocysts. Pregnancies were verified by ultrasound at
approximately embryonic day-30 and again at day-60. On day 69-70 post-insemination
/activation, recipient animals were slaughtered at a local abattoir. Cotyledonary tissue
was collected within thirty min of slaughter, snap frozen and stored in cryovials in liquid
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N2 until RNA extraction. Cotyledons were collected from three AI pregnancies and
four SCNT pregnancies.
RNA Extraction
RNA extraction from embryos. Total RNA was extracted and DNA was digested
with DNase I from AI and NT embryos using the RNAqueous micro kit (Ambion Inc.)
according to manufacturer’s recommendations with modifications. Prior to RNA
extraction each sample was spiked with 50 µg yeast tRNA as a carrier. The RNA was
eluted from the RNAqueous column using two 20-µll volumes of pre-warmed
pre
(75° C)
elution solution. Following RNA purification microarray samples were reduced to 3-5 µl
using speed vacuum centrifugation in order to yield a sufficient RNA concentration for
amplification using the Affymetrix 2-round labeling kit. All of the RNA extracted from
the first three groups of ten AI and SCNT embryos was utilized for the microarray
experiments, and a second group of embryos was collected and RNA-extracted for QPCR validation. In order to obtain sufficient RNA for Q-PCR reactions, the RNA was
amplified using the TargetAmp 2-Round Amplification Kit 2.0 (Epicentre, Madison, WI
53713). Amplified RNA was reverse-transcribed and stored at -20ºC until Q-PCR
analysis.
RNA extraction from cotyledons. Cotyledons were removed from liquid N2, and
approximately 30 mg of tissue was placed in RLT Buffer (Qiagen Inc., Valencia, CA
91355) containing beta-mercapto ethanol (βME) and subsequently homogenized using a
rotor stator homogenizer. The RNA extraction was performed using the RNeasy Mini
RNA Extraction Kit (Qiagen) according to manufacturer’s recommendations.
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Microarray Expression Studies
For the embryo microarray studies, previous experience as well as personal
communications with other researchers indicated RNA concentration- and qualitydetermination using the nanodrop and bioanalyzer are ineffective with RNA extracted
from embryos, so preliminary checks of RNA were not performed on embryonic RNA.
Blastocyst stage bovine embryos contain approximately 2 ng total RNA, in order to attain
sufficient quantities of RNA for hybridization on Affymetrix GeneChips a two-round
labeling protocol was used. Following the two-round labeling procedure RNA quantity
and integrity were assessed using an Agilent 2100 Bioanalyzer. Following quality
assessment, labeled RNA was hybridized to the Affymetrix bovine microarray chip and
subsequently scanned according to manufacturer’s protocols. Microarray analysis of
cotyledons was also performed according to manufacturer’s protocols. Since sufficient
RNA could be obtained from cotyledons, single-round labeling was used rather than the
two-round labeling. Following microarray analysis, Q-PCR of cotyledon RNA and
amplified blastocyst RNA was used to validate microarray data.
Reverse Transcription and SYBR Green Q-PCR
Reverse transcription was performed using Superscript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA 92008) with random primers. The cDNA was stored at -20°C
until use. SYBR Green real-time PCR (Abgene, Rochester, NY 14610) was used to
validate differential expression of genes in cotyledons and blastocysts that was
determined, by microarray analysis, to be differentially expressed. Each real-time PCR
reaction was performed in duplicate. Q-PCR was performed in white thin-walled 96-well
plates. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal
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control housekeeping gene as it has been determined to be the most reliable
housekeeping gene in bovine pre-implantation embryos (Robert et al. 2002). Primers for
Q-PCR analysis (Table 4-1) were designed using Primer3 primer-design software (Rozen
and Skaletsky 2000). A standard PCR protocol with a 15µL reaction volume was used.
The reactions consisted of Absolute™ QPCR SYBR® Green PCR Master Mix (Abgene)
containing fluorescein reference dye, forward and reverse primers at 200-300 nM final
concentration and 1 µL diluted template cDNA. The same PCR protocol was used for all
primers: 15 min at 95°C for activation of the hot start Thermo-Start® DNA Polymerase;
40 cycles of 95°C for 15 sec, 58°C for 30 sec, and 72°C for 15 sec (data collection step),
then 95°C for 30 sec followed by an 80-cycle melt curve initiated by 30 sec at 55°C with
a temperature increase of 0.5°C each cycle.
Statistical analysis
Analysis of cotyledon microarray data. After RMA (Irizarry et al. 2003)
preprocessing the limma/eBayes model (Smyth 2004) was applied to the data to test for
differential expression between controls and clones. As all of the clones were bulls, and
two of the controls were heifers, a gender covariate was added to the model. The results
of this preliminary probeset-level analysis did not yield any significant genes when
controlling the false discovery rate at 0.05.
The inability of more traditional probeset-level models to detect significance in
these data motivated a consideration of various probe-level models, which have
performed favorably in previous applications (Bolstad 2004). RMA background
correction and quantile normalization was performed, and again the limma/eBayes model
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with the gender covariate was applied to the data. By analyzing the data in this
manner, a number of genes were determined to be differentially expressed after
controlling the false discovery rate (FDR) at 0.05 (adjusted p-value [q]<0.05).
Analysis of embryo microarray data. Similar to the cotyledon data, after RMA
(Irizarry et al. 2003) preprocessing the limma/eBayes model (Smyth 2004) was fit to the
data to test for differential expression between controls and clones. Unlike the cotyledon
data, after controlling the FDR at 0.05 differentially expressed genes were found using
the probeset-level data (q<0.05).
Q-PCR analysis. The delta-delta Ct method (∆∆Ct) was used for real-time PCR
data evaluation (Livak and Schmittgen 2001). Data was normalized for differing amounts
of input cDNA using ∆Ct (Ct for the GAPDH housekeeping gene minus Ct for the gene
of interest). Next, ∆∆Ct was calculated by subtracting the ∆Ct of each sample from the
∆Ct of a reference cDNA sample. The n-fold increase or decrease in expression levels of
each gene at each embryonic stage was calculated using the formula 2-∆∆Ct. Pair-wise
comparisons between SCNT- and AI-∆∆Ct values were performed for each gene using
the Student’s t-test. A probability of P<0.05 was considered significant.
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Table 4-1 Details for primer sequences used in SYBR Green Q-PCR analyses.

Primer name
GAPDH
MHCI JSP.1
LOC540552
LOC533044

LOC782061
MGC142541
LOC613334
RBP1
MGC139085
LOC540923
MGC142636
LOC528380
IL6
PAG10
B4GALT1
LOC515356
KRT10
TKDP5
TKDP3
TSPAN1
LOC514936
MGC139339
MGC139527

Sequence forward, reverse (5'-3')
Primers used in both experiments
GATTGTCAGCAATGCCTCCT
TTGAGCTCAGGGATGACCTT
TCCTTGTCACTGGAGCTGTG
ACAGACGCATTCAGATGCAG
TGTTGGAGTTGTTCCTTGCT
ACAGCCACAAAAATGTCCTG
TTACGTTTTCAACGGCTGTG
TCACTGGCCAAACACCATAA
Cotyledon primers
CAAGCAGCTGGAGAAGATCC
TCCAAGAGAAAGGGGAGGTT
TGTGGAAGTTTCTGCACTGG
CATGTTTGGCAGCTTAGCAA
GCAGTGAAAATGCTGATGGA
CTCTCAGAGGGGCAAAACAG
CGACTTTACCGGGTACTGGA
TCAAACTCCTTCCCAACCTG
CTCCCTGAACTGGCATTCTC
GTTCTGAGGCCCTCTCTCCT
TGCCTGGAGCCAGTCTACTT
AGAGGGGCTTCCTAAAGCTG
GACGCTCACAGAGGAAGACC
GTCGGCTTTCCTCTTCTCCT
CCACTTTGCTGCTGACTTGA
GCTGCATTTGACTCAGAAAGG
TGCAGTCTTCAAACGAGTGG
TAAGTTGTGTGCCCAGTGGA
GAATGGGACAGTGGTTGCTT
AAGACAGCAGGAGGCAGTGT
CAGTGATAGGCCCTCTCTGC
GCTTTGATTCTTTGGGGTGA
TGTGAGCAGAGACTGGATCG
AGCTTAGAGGGGGACAGAGC
CAAAGCTGCCTCCATAGCTC
ATCCCTCAGAATTTCGAGCA
ACGGTGGCTGTAATGGAAAG
GGAAAGGAAAAGGCAGGTTC
TATCATCCGTGGTGTGGCTA
GTGCCGTGACCTACCACTTT
ACCACTGCTGCTGTCGTATG
GGGCTCTGGAATAGGAGGAC
AAGCCACTTCAGCCACAGTT
AGGAAGGACAAAGGGGAAGA
TCCTACGACATCCACTGCAC
CCCCTACCCTCTCTTGATCC
GCCTTTTTGTTTTCTGTTTGG
ATATTGCCAAGGAGCTGGTG

Size
(bp)

Primer name

240

LOC511508

240

LOC510084

115

LOC614726

235

S-N33
LOC616217

201
IER3
199
TL21877
216
DR1
207
TL24300
207
LOC513234
244
LOC514267
175
MGC152029
210
LOC539967
182
LOC539627
177
LOC785489
185
LOC785058
211
MGC29463
200
S-Laminin
230
S-NID-2
246
LOC786956
195
MGC143403
219
TL12963
192
ANXA1
209
PAH
ANXA4
LOC507982

Sequence forward, reverse (5'-3')
Embryo primers
TGGCACACGTTGTTGATTTT
GATGAAGCAAAGGGACCAAA
TTCTTGGGGTGTTCTGCTTT
CGGAGGACACTGGTTTTGTT
TGGACCGTGTAGGAAAAAGG
AGCACTCAGCCCACAAACTT
TCGTGGCAGAGTCACACATT
GGTAGCCGTGGTACTTGGAA
CAGTTTTTAATGCGCAAGCA
AAGCTGTCTTTCTGGGCAAA
GCAAGCACCCAGAACTAAGC
TTCCCCGAATCTTCACAGAC
GGCATTGCTTCCATTTGATT
CAATGAGAAACAGAGGAAAATCG
TGCTTAGGTTGCATTGGTTG
TGCCATTTCAAAGGAAGCAT
TCCCTGGAAGTGTTTCCAAC
TCCTACCCATCAAGAAGCTCA
GCGACAGTGGAGACAACAGA
GAACCTGCACAGGCTTCTTC
TGCCTTCATGTTATGCGGTA
GCCTTGTGAAAGCACCTCTC
TGCCTTTAGCTCATGTCGTG
GGTTCTTTGGTGCGAATTGT
CAAGGAAGTCCTGCCTTCAG
AAGGCTGGCTCCTGTGAATA
ACATGGACAAGGCACATTGA
ACTGTACCCCAAATCCCACA
AAGGGGTCTGTGTCTGTTGG
TGGGACACACAGCGTACATT
AGTTGCCCGAAGGTACTGTG
TTCAGTCCAGCTTTCCCAAG
CAGTGAGGAGGGTGGGATAA
GGGGTTTGGAGTTCAGCATA
TCGGGAATCTCTTTGAGGAA
GAACTTGTGGTGGAGGCATT
CCCTTCTCCAAACTGCTCTG
TCCCTTCTCCAGTCGGTATG
CAGAAGAGGTGCTCCCTCAC
TGAACAGAATGCCAAGGACA
GGAGAAAGCACACGAAGGAG
CCCCATTGCTAGTGTCCATT
ATGCCACATTGCAAAAGATG
TGCCCAAACATAGTCTCACA
AAGGCTTTGCTTTCTCTTGC
GACGAGTTCCAATACCCTTCA
TGCTTGCTATGAGCACAACC
GCAGTGGAAGACTCGGAAAG
AAATCCATGAAGGGCTTGG
GGGAATCTTCCTGGGCTTT
CAAGCACCCTGACCAACATT
CCTCCGTGCCCTTAGAGTTT

Size
(bp)
171
237
169
192
209
154
247
207
202
206
201
250
215
215
236
160
231
184
161
178
167
258
346
193
221
151

Results
By using an array-level model to fit the embryo microarray data, 28 probes
representing 28 different genes were identified as being differentially expressed (q<0.05)
with the FDR controlled at 0.05 (Table 4-2). By applying the probe-level model to the
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cotyledon data only 93 probes had a q-value of less than 1. Of those 93, 22 probes
representing 19 different genes were identified as significantly differentially expressed
(q<0.05), controlling the FDR at 0.05 (Table 4-3).
Table 4-2 Microarray data for blastocyst experiments.
Gene Symbol
Gene Name
Over-expressed in SCNT blastocysts
LOC540552
hypothetical LOC540552
*S-NID-2
similar to NID-2
PAH
phenylalanine hydroxylase
LOC533044
similar to Phosphoserine aminotransferase 1
TL21877
Transcribed locus
MHCI JSP.1
MHC Class I JSP.1
LOC614726
Similar to adaptor protein Lnk
LOC785058
hypothetical protein LOC785058
LOC507982
similar to WDSUB1 protein
ANXA4
annexin A4
ANXA1
annexin A1
*S-N33
strong similarity to protein sp:Q13454 (H.sapiens) N33_HUMAN N33 protein
MGC152029
similar to source of immunodominant MHC-associated peptides
*S-Laminin
similar to Laminin beta-1 chain precursor
DR1
down-regulator of transcription 1, TBP-binding (negative cofactor 2)
LOC511508
similar to KIAA0438
TL12963
transcribed locus
LOC785489
similar to O-acyltransferase (membrane bound) domain containing 2
MGC143403
similar to coronin, actin binding protein, 1C
LOC539967
hypothetical LOC539967
MGC29463
hyp protein
LOC539627
similar to KIAA0551 protein
LOC514267
hypothetical LOC514267
LOC786956
hypothetical protein LOC786956
LOC510084
similar to ankyrin repeat domain 10
TL24300
Transcribed locus
Reduced expression in SCNT blastocysts
LOC513234
similar to ovary-specific acidic protein
LOC616217
hypothetical LOC616217
IER3
immediate early response 3

Fold change

Q-value

NCBI ID

19.16
12.04
8.77
7.59
5.54
5.12
4.85
4.84
4.63
4.19
3.74
3.65
3.51
3.39
3.36
3.30
3.24
3.04
3.03
2.88
2.88
2.41
2.23
2.20
2.05
2.01

0.018
0.018
0.028
0.049
0.035
0.122
0.037
0.037
0.018
0.018
0.037
0.037
0.037
0.037
0.049
0.045
0.037
0.037
0.037
0.037
0.028
0.037
0.039
0.038
0.049
0.038

CB534828
CK770586
CK849069
CB166901
BF707348
M21044.1
AW670030
BM433653
AW307635
M22248.1
NM_175784.2
CB534173
CK849836
CK849175
AW356106
BI536262
CF930841
AW658325
CB428145
BM480824
AU276541
CB221260
CK780156
CK947614
CK770463
BP100594

3.24
4.38
4.26

0.038
0.037
0.037

CK778634
BF045590
CK775895

Fold change

Q-value

NCBI ID

3.90
3.45
3.03
2.68
2.32
2.24
2.13
1.93
1.89
1.86
1.57

0.001
0.023
0.002
<0.001
0.007
0.004
0.001
0.253
0.046
0.004
0.219

NM_176621.2
BE682514
BP108664
CK847894
NM_173923.2
CK849502
NM_177512.2
M21044.1
BF652540
CK847262
CB534828

4.77
2.68
2.20
2.15
1.99
1.82
1.75
1.74
1.69
1.66
1.52

0.001
0.001
0.012
0.001
0.015
0.019
0.021
0.009
0.050
0.006
0.434

AY135401.1
CK847504
CK957614
CK771895
BI849604
CK770131
CK778163
CK959273
NM_174377.1
BM088453
CB166901

Table 4-3 Microarray data for cotyledon experiments.
Gene Symbol
Gene Name
Over-expressed in SCNT cotyledons
PAG10
pregnancy-associated glycoprotein 10
TKDP3
trophoblast Kunitz domain protein 3
TKDP5
trophoblast Kunitz domain protein 5
MGC139527
similar to Sorting nexin-10
IL6
interleukin 6
MGC139339
similar to Cell death-inducing DFFA-like effector a
B4GALT1
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
MHCI JSP.1
MHC Class I JSP.1
LOC540923
similar to plasma glutamate carboxypeptidase
TSPAN1
tetraspanin 1
LOC540552
hypothetical LOC540552
Reduced expression in SCNT cotyledons
LOC782061
similar to AKR1C1 protein
LOC613334
similar to Fragile X mental retardation 1 neighbor
RBP1
retinol binding protein 1, cellular
LOC528380
Hypothetical LOC528380
MGC142541
similar to membrane-associated RING-CH protein III
LOC515356
similar to Cytochrome b5 domain containing 2
MGC142636
similar to carbonyl reductase 3
MGC139085
similar to paraoxonase 3
KRT10
keratin 10
LOC514936
hypothetical LOC514936
LOC533044
similar to Phosphoserine aminotransferase 1
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Comparison of the lists of differentially expressed genes showed no genes that
were common to both data sets, however two of the genes that were differentially
expressed in embryos were among the list of 93 genes whose differential expression
approached significance in the cotyledon data. In addition MHCI approached significance
in both data sets. Expression of MHCI was analyzed in embryos and cotyledons because
it approached significance in both groups and based on previous reports of its overexpression in cloned bovine placenta (Davies et al. 2004; Hill et al. 2002). In all, 22
genes were analyzed by Q-PCR in cotyledons, and 29 genes were analyzed in embryos.
Variability of gene expression levels between biological replicates was considerably
higher among cotyledons (Figure 4-1).
Following Q-PCR analysis of embryo cDNA, expression levels were found to
follow the same trends as microarray data for 25 of the 28 genes, and 9 were significantly
different based on Q-PCR results (Figure 4-2). In the case of the cotyledons, 19 of the 22
cotyledon genes followed the same trends as microarray data, however only two were
significantly different (Figure 4-3). By Q-PCR analysis expression of MHCI was
determined to be higher in SCNT blastocysts and cotyledons, but the difference was only
significant in the blastocysts. While microarray-based expression studies are a powerful
means of generating lists of differentially expressed candidate genes, Q-PCR is widely
accepted as a more robust test of differential expression. For this reason Q-PCR
validation is requisite for validation of microarray results.
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Figure 4-1 Heatmaps for embryo and cotyledon data. (A) 28 significant probe-sets
from embryo array data plus MHCI probe-set and (B) 22 significant probe-sets from
cotyledon array data (representing 19 different genes) plus MHCI and two probe-sets
that approached significance and were common to embryo data set. Control embryos
and cotyledons are labeled C, and SCNT embryos and cotyledons are labeled NT.
Dark red represents low expression, and dark blue represents high expression.

Discussion
For the embryo experiments, 28 genes were determined to be differentially
expressed between SCNT and AI blastocysts. Q-PCR analysis of those 28 genes verified
25 followed the same trend as predicted in the microarray data, however the differences
between SCNT and AI blastocysts were significant for only nine of those genes plus
MHCI (P<0.05). This disparity could be because only 6 chips were run in the experiment,
a marginal experiment size for even the best data. A relatively high degree of variability
between groups was observed in the Q-PCR results. The other factor that might account
for the validation rate of about 30% is that the RNA for the microarray and Q-PCR
experiments was derived from two separate embryo collections. This design lends
additional credibility to the study in that ten of the same genes were found to be
differentially expressed in both embryo collections. Interestingly, of the genes identified
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Figure 4-2 Relative gene expression in blastocysts based on Q-PCR analysis. The
yellow bars represent predicted SCNT expression relative to AI expression based on
microarray data, blue and maroon bars represent actual expression in SCNT and AI
blastocysts respectively as determined by Q-PCR. Genes are ordered by significance
based on microarray data from most-to-least. The y-axis represents scaled expression
values for purposes of comparison of SCNT, AI, and microarray-predicted SCNT
expression levels. Error bars represent SEM.
Note: for scaling purposes, some bars are truncated. Actual values are noted above
truncated bars.
* AI and SCNT gene expression differs significantly based on Q-PCR (P<0.05).
** Q-PCR results are opposite microarray predictions.

107
2.0

1.5

1.0

0.5

0.0
LOC528380

PAG10

B4GALT1

LOC515356

MGC142636*

TKDP3

LOC540923

IL6

LOC613334

MGC142541

LOC514936**

MGC139527

RBP1*

MGC139339

LOC782061

MGC139085

TSPAN1**

TKDP5
2.0

1.5

1.0

0.5

0.0
LOC533044

MHCI JSP.1

LOC540552**

KRT10

Figure 4-3 Relative gene expression in cotyledons based on Q-PCR analysis. The
yellow bars represent predicted SCNT expression relative to AI expression based on
microarray data, blue and maroon bars represent actual expression in SCNT and AI
cotyledons respectively as determined by Q-PCR. Genes are ordered by significance
based on microarray data from most-to-least. The y-axis represents scaled expression
values for purposes of comparison of SCNT, AI, and microarray-predicted SCNT
expression levels.Error bars represent SEM.
* AI and SCNT gene expression differs significantly based on Q-PCR (P<0.05).
** Q-PCR results are opposite microarray predictions.
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to be differentially expressed by microarray analysis, all but three were overexpressed in SNCT blastocysts.
At least two previous studies have evaluated global gene expression differences
between SNCT and control blastocysts (Smith et al. 2005; Somers et al. 2006). These
reports as well as the study reported here are similar in that they all report a relatively
small subset of genes that are differentially expressed between SCNT and control
blastocysts, indicating the majority of genes are reprogrammed to express the appropriate
genes at the appropriate levels by the blastocyst stage. One study evaluated global gene
expression patterns in bovine SCNT, IVF and AI blastocysts as well as expression
patterns in the donor cells. As expected, the donor cell gene expression patterns were far
divergent from the expression patterns in any of the blastocysts. Surprisingly SCNT
embryo expression profiles were more similar to AI embryos than IVF compared to AI.
Comparing SCNT and AI embryo expression patterns, fifty genes were found to be
differentially expressed while 198 genes were differentially expressed between AI and
IVF embryos (Smith et al. 2005). A similar study evaluating global gene expression
differences between bovine SCNT and IVF embryos reported 164 differentially
expressed genes (Somers et al. 2006). In the present study twenty eight genes were found
to be differentially expressed between SCNT and AI blastocysts. Q-PCR validation
seemed to follow similar patterns as well. The first study selected six genes for validation
by Q-PCR, and five were reported to validate microarray results, however statistical
treatment is not discussed (Smith et al. 2005). In the other study seven genes were
evaluated by Q-PCR, and of the seven only two were found to be significantly different
(Somers et al. 2006). The disparity between microarray and Q-PCR results reported in
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these two papers illustrate the importance of comprehensive Q-PCR validation of
microarray experiments. Accordingly, we applied Q-PCR analysis to every gene
determined by microarray analysis to be differentially expressed.
Interestingly, there do not appear to be any differentially expressed genes
common between these three studies. Likewise, there does not seem to be much
consensus between other gene expression studies evaluating expression differences
between SCNT and control bovine blastocysts (Daniels et al. 2000; Li et al. 2006;
Niemann et al. 2002; Oishi et al. 2006; Wrenzycki et al. 2004). The lack of concensus
between studies does not indicate any study is flawed; rather it emphasizes the need for
continued research to better understand the factors that affect gene expression following
SCNT. The impact of differences in nuclear transfer protocols and culture conditions on
gene expression likely explains the lack of consensus between experiments (Wrenzycki et
al. 2001).
Ten genes were verified by Q-PCR to be significantly different in SCNT
blastocysts. The majority of those genes are not well-annotated, but several were
identified as being similar to genes in other species. Genes similar to osteonidogen (Nid2), Laminin beta-1 (Lamb1), adaptor protein Lnk, tumor suppressor candidate 3 (N33),
and O-acyltransferase domain containing 2 (Oact2) were all identified as differentially
expressed as well as three hypothetical proteins- LOC540552, LOC786956, and
LOC785058. In addition, down-regulator of transcription 1 (Dr1) and MHCI were
identified by Q-PCR as significantly different. In every case, these genes were overexpressed in SCNT embryos.
NID-2 and LAMB1 have been shown to be important in development of the
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basement membranes (Kohfeldt et al. 1998). Adaptor protein Lnk is a broad inhibitor
of a number of growth factor and cytokine signaling pathways (Buza-Vidas et al. 2006).
N33 is a putative tumor suppressor involved in regulation of cell proliferation (Sun et al.
2004). The functions of Oact2, LOC540552, LOC786956, and LOC785058 are unknown.
DR1 binds to the TATA binding protein (TBP) and blocks the binding of RNA
polymerases II and III. In this way, DR1 can act as a potent transcriptional regulator
(White et al. 1994). If Dr1 is commonly over-expressed in SCNT embryos it could have a
profound impact on transcriptional regulation in early embryos. MHCI molecules are
important for antigen presentation associated with cell mediated immunity. The overexpression of MHCI in the bovine SCNT placenta has been reported previously and is
proposed as a factor in the frequent losses in bovine SCNT pregnancies (Hill et al. 2002).
MHCI expression has not been previously reported in bovine embryos. Evaluation of
MHCI expression in cotyledons found expression to be higher in SCNT cotyledons
compared with AI but not significantly.
Of the 19 genes predicted to be different between SCNT and AI cotyledons, only
two were verified to be significantly different by Q-PCR. This again reflects a large
degree of variability between samples. In fact, greater variability was observed between
cotyledon expression patterns than between embryo expression patterns. This is likely
due to the fact that multiple embryos were pooled to reduce variability in the microarray
and Q-PCR experiments, and cotyledons were analyzed individually. In addition, the
blastocysts were all subjected to essentially the same environment- in vitro culture
conditions for SCNT embryos and pre-implantation uterine environment for AI embryos.
Cotyledons were collected from different dams, and factors such as condition of the dam
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or nutrient demands of the fetus could easily impact gene expression in cotyledons.
The probe-level model did not prove to be a highly effective means of detecting
differentially expressed genes in the cotyledon experiments. Nevertheless, two genes
were validated by Q-PCR to be significantly different, and these genes might be of
physiological importance. A gene similar to carbonyl reductase 3 (Cbr3) was found to be
under-expressed, and retinol binding protein 1 (Rbp1) was over-expressed in day-70
SCNT cotyledons. CBR3 is a cytosolic enzyme that catalyzes the reduction of
prostaglandins, steroids and other carbonyls (Forrest and Gonzalez 2000). The function
of CBR3 has not yet been characterized in the placenta. RBP1 serves as the carrier
protein for retinol (vitamin A), a vitamin critical for normal embryonic development.
Either an excess or a deficiency in vitamin A can result in embryonic defects (Cohlan
1953; Ross et al. 2000).
The physiological relevance of the genes determined by microarray analysis and
Q-PCR to be differentially expressed in SCNT blastocysts and cotyledons has not yet
been elucidated. Continued research evaluating the role of these genes in development is
required, however several of the genes merit further research based on function; in
particular Dr1, MHCI, and Rbp1.
The data presented here as well as in a number of other studies evaluating gene
expression differences between clones and controls all lend support to the idea that
incomplete epigenetic reprogramming lies at the heart of poor SCNT efficiency.
Unfortunately a large degree of variability is observed in every aspect of SCNT, from
rates of in vitro development to differences in pregnancy establishment and maintenance
rates. The variability even extends to phenotypes of genetically identical cloned offspring
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(Lee et al. 2004). It can arise from differences in manipulation or culture conditions
(Wrenzycki et al. 2001), donor cell type (Batchelder et al. 2005; Powell et al. 2004),
oocyte source (Chapter 2; Miyoshi et al. 2003), and a host of other factors. Continued
global gene expression studies under a variety of conditions will shed light on some of
the factors most important in the nuclear reprogramming process as well as offer insights
into the complex and poorly characterized field of epigenetic reprogramming. Until the
factors affecting reprogramming efficiency are better characterized or methods for
augmentation of epigenetic reprogramming are developed, it is unlikely SCNT efficiency
will improve to any great degree.
References
Batchelder CA, Hoffert KA, Bertolini M, Moyer AL, Mason JB, Petkov SG, Famula TR,
Anderson GB. 2005. Effect of the nuclear-donor cell lineage, type, and cell donor
on development of somatic cell nuclear transfer embryos in cattle. Cloning Stem
Cells 7(4):238-254.
Bolstad BM. 2004. Low Level Analysis of High-density Oligonucleotide Array Data:
Background, Normalization and Summarization. [Ph.D. Dissertation, University
of California, Berkeley].
Buza-Vidas N, Antonchuk J, Qian H, Mansson R, Luc S, Zandi S, Anderson K, Takaki S,
Nygren JM, Jensen CT, Jacobsen SE. 2006. Cytokines regulate postnatal
hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK.
Genes Dev 20(15):2018-2023.
Campbell KH, Alberio R, Choi I, Fisher P, Kelly RD, Lee JH, Maalouf W. 2005.
Cloning: eight years after Dolly. Reprod Domest Anim 40(4):256-268.

113
Cohlan SQ. 1953. Excessive intake of vitamin A as a cause of congenital anomalies
in the rat. Science 117(3046):535-536.
Constant F, Guillomot M, Heyman Y, Vignon X, Laigre P, Servely JL, Renard JP,
Chavatte-Palmer P. 2006. Large offspring or large placenta syndrome?
Morphometric analysis of late gestation bovine placentomes from somatic nuclear
transfer pregnancies complicated by hydrallantois. Biol Reprod 75(1):122-130.
Daniels R, Hall V, Trounson AO. 2000. Analysis of gene transcription in bovine nuclear
transfer embryos reconstructed with granulosa cell nuclei. Biol Reprod
63(4):1034-1040.
Davies CJ, Hill JR, Edwards JL, Schrick FN, Fisher PJ, Eldridge JA, Schlafer DH. 2004.
Major histocompatibility antigen expression on the bovine placenta: its
relationship to abnormal pregnancies and retained placenta. Anim Reprod Sci 8283:267-280.
Dean W, Santos F, Reik W. 2003. Epigenetic reprogramming in early mammalian
development and following somatic nuclear transfer. Semin Cell Dev Biol
14(1):93-100.
Enright BP, Jeong BS, Yang X, Tian XC. 2003. Epigenetic characteristics of bovine
donor cells for nuclear transfer: levels of histone acetylation. Biol Reprod
69(5):1525-1530.
Enright BP, Sung LY, Chang CC, Yang X, Tian XC. 2005. Methylation and acetylation
characteristics of cloned bovine embryos from donor cells treated with 5-aza-2'deoxycytidine. Biol Reprod 72(4):944-948.
Forrest GL, Gonzalez B. 2000. Carbonyl reductase. Chem Biol Interact 129(1-2):21-40.

114
Gao T, Zheng J, Xing F, Fang H, Sun F, Yan A, Gong X, Ding H, Tang F, Sheng HZ.
2007. Nuclear reprogramming: the strategy used in normal development is also
used in somatic cell nuclear transfer and parthenogenesis. Cell Res 17(2):135-150.
Han DW, Song SJ, Uhum SJ, Do JT, Kim NH, Chung KS, Lee HT. 2003. Expression of
IGF2 and IGF receptor mRNA in bovine nuclear transferred embryos. Zygote
11(3):245-252.
Heyman Y, Chavatte-Palmer P, LeBourhis D, Camous S, Vignon X, Renard JP. 2002.
Frequency and occurrence of late-gestation losses from cattle cloned embryos.
Biol Reprod 66(1):6-13.
Hill JR, Burghardt RC, Jones K, Long CR, Looney CR, Shin T, Spencer TE, Thompson
JA, Winger QA, Westhusin ME. 2000. Evidence for placental abnormality as the
major cause of mortality in first-trimester somatic cell cloned bovine fetuses. Biol
Reprod 63(6):1787-1794.
Hill JR, Roussel AJ, Cibelli JB, Edwards JF, Hooper NL, Miller MW, Thompson JA,
Looney CR, Westhusin ME, Robl JM, Stice SL. 1999. Clinical and pathologic
features of cloned transgenic calves and fetuses (13 case studies). Theriogenology
51(8):1451-1465.
Hill JR, Schlafer DH, Fisher PJ, Davies CJ. 2002. Abnormal expression of trophoblast
major histocompatibility complex class I antigens in cloned bovine pregnancies is
associated with a pronounced endometrial lymphocytic response. Biol Reprod
67(1):55-63.
Hoffert KA, Batchelder CA, Bertolini M, Moyer AL, Famula TR, Anderson DL,
Anderson GB. 2005. Measures of maternal-fetal interaction in day-30 bovine
pregnancies derived from nuclear transfer. Cloning Stem Cells 7(4):289-305.

115
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. 2003. Summaries
of Affymetrix GeneChip probe level data. Nucleic Acids Res 31(4):e15.
Kang YK, Koo DB, Park JS, Choi YH, Kim HN, Chang WK, Lee KK, Han YM. 2001.
Typical demethylation events in cloned pig embryos. Clues on species-specific
differences in epigenetic reprogramming of a cloned donor genome. J Biol Chem
276(43):39980-39984.
Kang YK, Park JS, Koo DB, Choi YH, Kim SU, Lee KK, Han YM. 2002. Limited
demethylation leaves mosaic-type methylation states in cloned bovine preimplantation embryos. Embo J 21(5):1092-1100.
Kang YK, Yeo S, Kim SH, Koo DB, Park JS, Wee G, Han JS, Oh KB, Lee KK, Han
YM. 2003. Precise recapitulation of methylation change in early cloned embryos.
Mol Reprod Dev 66(1):32-37.
Kohfeldt E, Sasaki T, Gohring W, Timpl R. 1998. Nidogen-2: a new basement membrane
protein with diverse binding properties. J Mol Biol 282(1):99-109.
Lee RS, Peterson AJ, Donnison MJ, Ravelich S, Ledgard AM, Li N, Oliver JE, Miller
AL, Tucker FC, Breier B, Wells DN. 2004. Cloned cattle fetuses with the same
nuclear genetics are more variable than contemporary half-siblings resulting from
artificial insemination and exhibit fetal and placental growth deregulation even in
the first trimester. Biol Reprod 70(1):1-11.
Li GP, Bunch TD, White KL, Aston KI, Meerdo LN, Pate BJ, Sessions BR. 2004a.
Development, chromosomal composition, and cell allocation of bovine cloned
blastocyst derived from chemically assisted enucleation and cultured in
conditioned media. Mol Reprod Dev 68(2):189-197.

116
Li GP, White KL, Aston KI, Meerdo LN, Bunch TD. 2004b. Conditioned medium
increases the polyploid cell composition of bovine somatic cell nucleartransferred blastocysts. Reproduction 127(2):221-228.
Li X, Amarnath D, Kato Y, Tsunoda Y. 2006. Analysis of development-related gene
expression in cloned bovine blastocysts with different developmental potential.
Cloning Stem Cells 8(1):41-50.
Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402408.
Mann MR, Chung YG, Nolen LD, Verona RI, Latham KE, Bartolomei MS. 2003.
Disruption of imprinted gene methylation and expression in cloned
preimplantation stage mouse embryos. Biol Reprod 69(3):902-914.
Miyoshi K, Rzucidlo SJ, Pratt SL, Stice SL. 2003. Improvements in cloning efficiencies
may be possible by increasing uniformity in recipient oocytes and donor cells.
Biol Reprod 68(4):1079-1086.
Niemann H, Wrenzycki C, Lucas-Hahn A, Brambrink T, Kues WA, Carnwath JW. 2002.
Gene expression patterns in bovine in vitro-produced and nuclear transfer-derived
embryos and their implications for early development. Cloning Stem Cells
4(1):29-38.
Oback B, Wells DN. 2007. Cloning cattle: the methods in the madness. Adv Exp Med
Biol 591:30-57.
Oishi M, Gohma H, Hashizume K, Taniguchi Y, Yasue H, Takahashi S, Yamada T,
Sasaki Y. 2006. Early embryonic death-associated changes in genome-wide gene

117
expression profiles in the fetal placenta of the cow carrying somatic nuclearderived cloned embryo. Mol Reprod Dev 73(4):404-409.
Powell AM, Talbot NC, Wells KD, Kerr DE, Pursel VG, Wall RJ. 2004. Cell donor
influences success of producing cattle by somatic cell nuclear transfer. Biol
Reprod 71(1):210-216.
Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian
development. Science 293(5532):1089-1093.
Robert C, McGraw S, Massicotte L, Pravetoni M, Gandolfi F, Sirard MA. 2002.
Quantification of housekeeping transcript levels during the development of
bovine preimplantation embryos. Biol Reprod 67(5):1465-1472.
Rosenkrans CF, Jr., First NL. 1994. Effect of free amino acids and vitamins on cleavage
and developmental rate of bovine zygotes in vitro. J Anim Sci 72(2):434-437.
Ross SA, McCaffery PJ, Drager UC, De Luca LM. 2000. Retinoids in embryonal
development. Physiol Rev 80(3):1021-1054.
Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist
programmers. Methods Mol Biol 132:365-386.
Santos F, Zakhartchenko V, Stojkovic M, Peters A, Jenuwein T, Wolf E, Reik W, Dean
W. 2003. Epigenetic marking correlates with developmental potential in cloned
bovine preimplantation embryos. Curr Biol 13(13):1116-1121.
Schrader AD, Iqbal MJ, Jones KL. 2003. Gene expression in cloned bovine fetal liver.
Cloning Stem Cells 5(1):63-69.
Shi W, Haaf T. 2002. Aberrant methylation patterns at the two-cell stage as an indicator
of early developmental failure. Mol Reprod Dev 63(3):329-334.

118
Smith SL, Everts RE, Tian XC, Du F, Sung LY, Rodriguez-Zas SL, Jeong BS,
Renard JP, Lewin HA, Yang X. 2005. Global gene expression profiles reveal
significant nuclear reprogramming by the blastocyst stage after cloning. Proc Natl
Acad Sci USA 102(49):17582-17587.
Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential
expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3.
Somers J, Smith C, Donnison M, Wells DN, Henderson H, McLeay L, Pfeffer PL. 2006.
Gene expression profiling of individual bovine nuclear transfer blastocysts.
Reproduction 131(6):1073-1084.
Sun F, Fang H, Li R, Gao T, Zheng J, Chen X, Ying W, Sheng HZ. 2007. Nuclear
reprogramming: the zygotic transcription program is established through an
"erase-and-rebuild" strategy. Cell Res 17(2):117-134.
Sun X, Gulyas M, Hjerpe A. 2004. Mesothelial differentiation as reflected by differential
gene expression. Am J Respir Cell Mol Biol 30(4):510-518.
Wells DN, Misica PM, Tervit HR. 1999. Production of cloned calves following nuclear
transfer with cultured adult mural granulosa cells. Biol Reprod 60(4):996-1005.
White RJ, Khoo BC, Inostroza JA, Reinberg D, Jackson SP. 1994. Differential regulation
of RNA polymerases I, II, and III by the TBP-binding repressor Dr1. Science
266(5184):448-450.
Wrenzycki C, Herrmann D, Lucas-Hahn A, Lemme E, Korsawe K, Niemann H. 2004.
Gene expression patterns in in vitro-produced and somatic nuclear transferderived preimplantation bovine embryos: relationship to the large offspring
syndrome? Anim Reprod Sci 82-83:593-603.

119
Wrenzycki C, Wells D, Herrmann D, Miller A, Oliver J, Tervit R, Niemann H. 2001.
Nuclear transfer protocol affects messenger RNA expression patterns in cloned
bovine blastocysts. Biol Reprod 65(1):309-317.
Young LE, Beaujean N. 2004. DNA methylation in the preimplantation embryo: the
differing stories of the mouse and sheep. Anim Reprod Sci 82-83:61-78.

120
CHAPTER 5
ABERRANT EXPRESSION OF TRANSCRIPTION FACTORS AND OTHER
GENES IN VARIOUS STAGES OF PREIMPLANTATION BOVINE
SOMATIC CELL NUCLEAR TRANSFER EMBRYOS
Abstract
Based on microarray data comparing gene expression of fibroblast donor cells and
bovine somatic cell nuclear transfer (SCNT) and in vivo produced (AI) blastocysts, a
group of genes including several transcription factors was selected for expression studies.
Using SYBR green-based real-time PCR (Q-PCR) the expression levels of POU domain
class 5 transcription factor (Oct4), snail homolog 2 (Snai2), annexin A1 (Anxa1),
thrombospondin (Thbs), tumor-associated calcium signal transducer 1 (Tacstd1), and
transcription factor AP2 gamma (Tfap2c) were evaluated in bovine fibroblasts, oocytes,
embryos 30 min post-fusion (SCNT), 12 h post-fertilization/activation, as well as 2-cell,
4-cell, 8-cell, morula, and blastocyst-stage in vitro fertilized (IVF) and SCNT embryos.
For every gene except Oct4, levels of expression were indistinguishable between IVF and
SCNT embryos at the blastocyst stage, however in many cases expression of these genes
during stages prior to blastocyst differed significantly. Altered levels of gene expression
early in development likely have developmental consequences downstream. These results
indicate that experiments evaluating gene expression differences between control and
SCNT blastocysts may underestimate the degree of difference between clones and
controls and further offer insights into the dynamics of gene reprogramming following
SCNT.

121
Introduction
While SCNT has been successfully applied to a large and growing number of
species since Dolly, the success rate of the technology in producing live, healthy
offspring is quite low. In cattle approximately 10-15% of transferred SCNT embryos
result in live births (Oback and Wells 2007). Following transfer of a donor cell or nucleus
into an enucleated oocyte, cell-type-specific epigenetic marks must be removed from
chromatin as the DNA is transformed from a differentiated state to the totipotent state
required for proper embryo development in the process of nuclear reprogramming. The
oocyte is well-equipped to perform this process on maternal and paternal DNA following
fertilization; however, it often seems to be insufficient for reprogramming a differentiated
donor cell following SCNT. Inefficient or incomplete nuclear reprogramming of the
donor nucleus is generally recognized as a major cause for the low success rates observed
with SCNT (Beyhan et al. 2007; Bourc'his et al. 2001; Dean et al. 2003). This hypothesis
is supported by a number of publications that report a variety of deficiencies in nuclear
reprogramming of SCNT embryos including differences in global DNA methylation
(Bourc'his et al. 2001; Dean et al. 2001; Kang et al. 2002; Shi and Haaf 2002) and histone
modifications (Enright et al. 2003; Enright et al. 2005) as well as many reports of
aberrant gene expression in cloned embryos (Chapter 4; Beyhan et al. 2007; Bortvin et al.
2003; Li et al. 2006; Niemann et al. 2002; Smith et al. 2005; Somers et al. 2006).
Incomplete nuclear reprogramming following SCNT is manifest in a variety of
ways. Low rates of development and pregnancy establishment (Hill et al. 2000; Powell et
al. 2004) as well as high rates of pregnancy failure throughout gestation (Heyman et al.
2002) and frequent postnatal loss are obvious indicators of deficiency in the SCNT
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process. Additionally, a variety of abnormalities can be observed in SCNT embryos,
fetuses, placentas, and neonates. Differences in cell number and cell allocations have
been observed in SCNT embryos as well as increased incidence of aneuploidy and
fragmented nuclei (Booth et al. 2003; Li et al. 2004a; Li et al. 2005a). Following embryo
transfer and pregnancy establishment a number of factors likely contribute to the high
rates of pregnancy failure. Abnormal placentation has been reported in a number of
species following SCNT (Constant et al. 2006; Fletcher et al. 2007; Hashizume et al.
2002; Ogura et al. 2002). In addition, fetal overgrowth (Constant et al. 2006),
hydroallantois (Lawrence et al. 2005), stillbirth, respiratory and circulatory problems
(Hill et al. 1999), and liver malformations have all been observed in clones (Li et al.
2005b). Most of these problems may directly result from the primary problem of
improper placentation.
A number of studies have undertaken to characterize abnormal gene expression
patterns following SCNT; however the majority of the studies have evaluated gene
expression in blastocysts, fetal tissues or placental tissues. Many studies have evaluated
the expression levels of specific genes important in early development in SCNT
blastocysts by Q-PCR. The list of genes reported to be differentially expressed in SCNT
blastocysts includes Mash2, DNMT1, Hsp 70.1, IFNτ, Cx43 (Niemann et al. 2002), Oct4
(Boiani et al. 2002), G6PD, Xist, Pgk (Wrenzycki et al. 2002),several imprinted genes
including IGF2 (Han et al. 2003), H19 and Snrpn (Mann et al. 2003), and many others. It
is important to note that factors such as activation protocol, stage of donor cells, and
culture conditions all impact gene expression in SCNT blastocysts (Wrenzycki et al.
2001).
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Evaluation of global gene expression patterns in bovine SCNT blastocysts
(Beyhan et al. 2007; Smith et al. 2005), placental tissue (Oishi et al. 2006) and liver
(Herath et al. 2006; Schrader et al. 2003) have also reported a number of differentially
expressed genes. Surprisingly these studies generally find fewer than 100 differentially
expressed genes when compared with controls. In global gene expression studies little-tono consensus exists in the lists of differentially expressed genes, likely a consequence of
different SCNT protocols utilized by different researchers.
A recent report evaluating global gene expression of mouse SCNT embryos
during the first two cell cycles illustrates the importance of evaluating gene expression
differences in early preimplantation embryos prior to the blastocyst stage in order to
appreciate the scope of the problems in gene expression following SCNT. It was found
that during the second cell cycle over 1000 genes were differentially expressed between
SCNT and control embryos indicating the reprogramming process occurs over several
cell cycles, and the divergence in gene expression patterns narrows greatly by the
blastocyst stage (Vassena et al. 2007).
While various studies report differential gene expression between SCNT and
control tissues, they do not attempt to determine the point in development when
expression levels in the SCNT tissues diverged from controls, nor do they address the
question of timing of reprogramming events. These questions are important in elucidating
mechanisms involved in epigenetic reprogramming following SCNT with the ultimate
goal of improving the efficiency of SCNT. Two recent studies evaluated the mechanisms
and timing of nuclear reprogramming globally following normal fertilization (Sun et al.
2007) and SCNT (Gao et al. 2007). Localization and activity of 20 different chromatin
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factors including transcription factors and transcriptional regulators was evaluated
through early preimplantation development, and it was determined that in the case of
normal fertilization and SCNT an “erase-and-rebuild” strategy for epigenetic
modifications was employed. This strategy involves the global removal of chromatin
factors prior to pronuclear formation followed by re-association of the factors after
pronuclear formation. While the mechanisms of epigenetic reprogramming were found to
be similar for IVF and SCNT embryos, the erasure of epigenetic marks as well as the reestablishment of new modifications was found to be both incomplete and delayed in
SCNT embryos (Gao et al. 2007).
The inefficiencies associated with SCNT, numerous reports of abnormal
epigenetic reprogramming manifest by gene specific and global gene expression
differences in SCNT embryos and fetal tissues, as well as the extremely limited
understanding of epigenetic reprogramming mechanisms following SCNT all provided
impetus for the present study. The aim of this study was to evaluate the dynamics of
nuclear reprogramming by measuring the relative levels of transcript abundance through
various stages of preimplantation development of several developmentally important
genes known to undergo a high degree of change in expression following SCNT. This
work was undertaken in an effort to gain insight into the timing of gene expression
regulation following SCNT with the ultimate goal of elucidating reprogramming
mechanisms. This is the first study to report detailed stage-by-stage gene expression
levels in preimplantation bovine SCNT embryos.

125
Materials and Methods
Donor Cell Culture
Primary bovine fibroblast cultures were established from either lung tissue or ear
biopsy. Previous data have demonstrated no difference in in vitro development between
lung- and ear-derived donor cells (Kato et al. 2000). Tissues were washed thoroughly and
minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone Laboratories, Logan, UT
84321) supplemented with 15% fetal bovine serum (FBS; HyClone Laboratories) and
100 U/ml penicillin/ 100 µg/ml streptomycin (HyClone Laboratories), seeded in 25 cm2
tissue culture flasks, and cultured at 39˚C in a humidified atmosphere of 5% CO2 in air
for several days. Cells between passages one and four were then harvested and resuspended in tissue culture medium containing 10% DMSO, frozen, and stored in liquid
N2 until use in microarray experiments or SCNT. Prior to gene expression studies cells
were thawed and expanded from about three million cells to approximately twenty seven
million cells through two passages. Cells utilized for SCNT were treated with trypsin
(.25%) and resuspended in manipulation medium prior to use.
Oocyte Maturation
Maturation of bovine oocytes was performed as described previously (Li et al.
2004a; Li et al. 2004b). Briefly, cumulus-oocyte-complexes (COCs) were aspirated from
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.
Only those oocytes with uniform cytoplasm and intact layers of cumulus cells were
selected and matured in TCM 199 containing 10% FBS, 0.5 µg/ml FSH (Sioux
Biochemicals, Sioux City, IA 51250), 5 µg/ml LH (Sioux Biochemicals), and 100 U/ml
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penicillin/ 100 µg/ml streptomycin for 18-22 h.
SCNT Embryo Production
Following maturation, cumulus cells were removed from oocytes by vortexing
COCs in PB1 (calcium- and magnesium-containing phosphate buffered saline [HyClone
Laboratories], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/ml BSA) medium
containing 10 mg/ml hyaluronidase. Oocytes with a first polar body were used as
recipient cytoplasts. Enucleation was employed to remove the first polar body and
metaphase plate, and single cells were subsequently transferred to the perivitelline space
of recipient cytoplasts. Fusions of NT couplets were performed in mannitol fusion
medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25 microseconds.
Following fusion, embryos were held in CR2 medium supplemented with 3% FBS for 12 h prior to activation (Rosenkrans and First 1994). Fused embryos were activated
between 23 and 25 h after the onset of maturation by exposure to 5 µM ionomycin for 5
min followed by five h incubation in 10µg/ml cycloheximide. For the purposes of the
microarray experiments we produced three groups of ten grade 1-2 blastocysts from a
single cell line. For the Q-PCR studies, three groups of five embryos each were collected
at each embryonic stage to be analyzed. Embryos were placed in RNAlater RNA
stabilization reagent (Ambion Inc., Austin, TX 78744) and stored at -20° C until RNA
extraction.
AI Embryo Production
Control embryos for microarray studies were collected from super-ovulated cows
using established protocols. Donor cows were synchronized using the EAZI-BREED™
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CIDR® vaginal progesterone implant. The CIDR was used for ten days followed by
an I.M. injection of 50 mg Lutalyse (PGF2α) (5 ml at 10 mg/ml). Animals were bred by
artificial insemination (AI) the morning following standing heat and again twelve and
twenty-four h after standing heat. Seven days after the initial breeding, embryos were
collected from donor animals by intra-uterine flush using embryo filters. Following
collection embryos were rinsed in flush medium, placed in RNAlater (Ambion Inc.) and
stored at -20° C until RNA extraction. Three groups of ten grade 1 and 2 blastocysts were
collected for the microarray studies.
IVF Embryo Production
IVF embryos were collected for the Q-PCR component of the study.
Cyropreserved bovine semen (Hoffman AI, Logan, UT) was thawed and live sperm were
separated by centrifugation on a 45%/95% layered Percoll gradient. Motile spermatozoa
obtained by this method were diluted in fert-TALP to a final concentration of 1.0 X 106
per ml (Reed et al. 1996). Capacitation occurred in fert-TALP containing heparin at a
concentration of 10 µg/ml. In vitro matured oocytes were fertilized in vitro for 18-20 h at
39°C in 5% CO2 and air. After the fertilization period, oocytes were vortexed in a 15-ml
conical centrifuge tube containing 1 ml of PB1 2 min 40 sec to completely remove
cumulus cells. Embryos were co-cultured with cumulus cells in CR2 medium
supplemented with 3% FBS (Rosenkrans and First 1994) at 39°C in 5% CO2 in air. Three
groups of five embryos each were collected at each embryonic stage to be analyzed.
Embryos were rinsed through several drops of PB1 and through a single drop of
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RNAlater then placed in RNAlater (Ambion Inc.) and stored at -20° C until RNA
extraction.
RNA Extraction
RNA extraction from donor cells. Cells were harvested by trypsinization, washed
with cell culture medium (DME/F12 1:1 supplemented with 15% Defined FBS [Hyclone
Laboratories] and Penicillin/Streptomycin) followed by a second wash with PBS.
Washed cells were pelleted and resuspended in RLT Buffer (Qiagen Inc., Valencia, CA
91355) containing beta-mercapto ethanol (βME) and subsequently homogenized using a
syringe with a 21-gauge needle. RNA extraction was performed using the RNeasy Mini
RNA Extraction Kit (Qiagen) according to manufacturer’s recommendations.
RNA extraction from embryos. Total RNA was extracted and DNA was digested
with DNase I from AI, IVF, and NT embryos using the RNAqueous micro kit (Ambion
Inc.) according to manufacturer’s recommendations with modifications. Prior to RNA
extraction each sample was spiked with 50 µg yeast tRNA as a carrier. The RNA was
eluted from the RNAqueous column using two 20 µll volumes of pre
pre-warmed (75° C)
elution solution. Following RNA purification, microarray samples were reduced to 3-5 µl
using speed vacuum centrifugation in order to yield sufficient RNA concentration for
amplification using the Affymetrix 2-round labeling kit, and Q-PCR samples were
immediately reverse-transcribed and stored at -20ºC until Q-PCR analysis.
Microarray Expression Studies
For the embryo microarray studies previous experience as well as personal
communications with other researchers indicated RNA concentration- and quality-
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determination using the nanodrop and bioanalyzer are ineffective with RNA extracted
from embryos, so preliminary checks of RNA were not performed on embryonic RNA.
Blastocyst stage bovine embryos contain approximately 2 ng total RNA so in order to
attain sufficient quantities of RNA for hybridization on Affymetrix GeneChips a tworound labeling protocol was used. After the two-round labeling procedure RNA quantity
and integrity were assessed using an Agilent 2100 Bioanalyzer. Following quality
assessment labeled RNA was hybridized to the Affymetrix bovine microarray chip and
subsequently scanned according to manufacturer’s protocols. Microarray analysis of
donor cells was also performed according to manufacturer’s protocols. Since sufficient
RNA could be obtained from donor cells, single-round labeling was used instead of the
two-round labeling. Following microarray analysis, Q-PCR of un-amplified SCNT and
IVF blastocyst cDNA was used to verify the differential expression of the six genes of
interest was real and not simply an artifact of the differences in labeling protocols.
Selection of Target Genes
Initially bovine SCNT and in vivo produced (AI) embryos (three groups of ten
embryos each SCNT and AI) along with several fibroblast donor cell lines were subjected
to microarray analysis to measure the degree of reprogramming that occurs between the
time of nuclear transfer and the blastocyst stage. Following microarray analysis (see
Chapter 4), several genes were selected for further analysis based on degree of change as
well as physiological importance. Thbs and Snai2 underwent dramatic down-regulation
following SCNT and Anxa1 underwent moderate down-regulation. Tacstd1 and Oct4
were of interest because they were highly expressed in blastocysts and expressed at low
levels or not at all in fibroblast donor cells. While Tfap2c was not represented on the
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microarray, this gene was known based on previous work in our laboratory to be
unexpressed in fibroblasts and strongly expressed in blastocysts.
Reverse Transcription and
SYBR Green Q-PCR
Reverse transcription was performed using Superscript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA 92008) with random primers. Optizyme Recombinant RNase
Inhibitor (Fisher Scientific, Fair Lawn, NJ 07410) was utilized at a concentration of 1
unit per µl during the reverse transcription of embryonic RNA. The cDNA was stored at
-20°C until use.
SYBR Green real-time PCR (Abgene, Rochester, NY 14610) was used to
characterize relative expression levels of Thbs, Snai2, Anxa1, Tacstd1, Oct4, and Tfap2c
in fibroblast cells and IVF and SCNT embryos. Expression levels were analyzed by at
various stages following fertilization or activation. Following SCNT, embryos 30 min
and 12 h post-activation and at the 2-cell, 4-cell, 8-cell, morula, and blastocyst stages
were analyzed. The thirty min-post-activation group was analyzed to establish a base-line
level of transcript abundance for each gene against which other stages could be
compared. An IVF thirty min-post-fertilization group was not collected because
fertilization times can vary following insemination, so the embryos collected would
exhibit unacceptable variability in terms of fertilization status and timing (Kim et al.
2002). IVF embryos were analyzed 16 h post-insemination (approximately 12 h postfertilization), and at the 2-cell, 4-cell, 8-cell, morula, and blastocyst stages. Embryos were
pooled in groups of five to provide sufficient RNA for reverse transcription and Q-PCR
analysis without the need for linear amplification, and the pooling of embryos served to
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minimize variability between replicates. Q-PCR was performed in white thin-walled
96-well plates, and each Q-PCR reaction was performed in triplicate. Glyceraldehyde-3phosphate dehydrogenase (Gapdh) was used as the internal control housekeeping gene as
it has been determined to be the most reliable housekeeping gene in bovine preimplantation embryos (Robert et al. 2002). Primers for Gapdh, Thbs, Snai2, Anxa1,
Tacstd1, Oct4, and Tfap2c (Table 5-1) were designed using Primer3 primer-design
software (Rozen and Skaletsky 2000). A standard PCR protocol with a 15µL reaction
volume was used. The reactions consisted of Absolute™ QPCR SYBR® Green PCR
Master Mix (Abgene) containing fluorescein reference dye, forward and reverse primers
at 200-300 nM final concentration and 1 µL diluted template cDNA. The same PCR
protocol was used for all primers: 15 min at 95°C for activation of the hot start ThermoStart® DNA Polymerase; 40 cycles of 95°C for 15 sec, 58°C for 30 sec, and 72°C for 15
sec (data collection step), then 95°C for 30 sec followed by an 80-cycle melt curve
initiated by 30 sec at 55°C with a temperature increase of 0.5°C each cycle.
Table 5-1 Details for genes analyzed and sequences of primers used in Q-PCR analyses.
Gene
GAPDH
THBS
SNAI2
ANXA1
TACSTD1
OCT4
TFAP2C

Primer name

Primer sequence (5’-3’)

GAPDH left
GAPDH right
THBS left
THBS right
SNAI2 left
SNAI2 right
ANXA1 left
ANXA1 right
TACSTD1 left
TACSTD1 right
OCT4 left
OCT4 right
TFAP2C left
TFAP2C right

GATTGTCAGCAATGCCTCCT
TTGAGCTCAGGGATGACCTT
ACACGACTGCAACAAGAACG
GGTTGGGGCAATTATCCTTT
GGCATTTTGTCTTGTGCTGA
TGCAATGTGCTTTTTGCTTC
AAGGCTTTGCTTTCTCTTGC
GACGAGTTCCAATACCCTTCA
CCAGGAAGGATGTGTGTGTG
GAGCCCGTCATTATTCTGGA
GTTTTGAGGCTTTGCAGCTC
CTCTCCAGGTTGCCTCTCAC
CTGCTCAGTCCCTGGAAGAC
AAGGTACGGCCACCATTTTT

Fragment size
(bp)
240
200
214
346
214
184
162

Position on
cDNA
500
720
2108
2288
1038
1232
608
933
284
478
856
1020
897
1039

NCBI RefSeq
NM_001034034
NM_174196
NM_001034538
NM_175784
NM_001035290
NM_174580
NM_001075509
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Statistical analysis
Microarray. The raw intensity data from the twelve microarray chips were
preprocessed together using the RMA algorithm (Irizarry et al. 2003). The limma/eBayes
test (Smyth 2004) was used to test for differential expression between the six donor cell
samples and the six embryo samples. The Benjamini-Hochberg adjustment (Benjamini
and Hochberg 1995) was applied to the resulting P-values, and the false discovery rate
(FDR) was controlled at 0.01.
Q-PCR. The delta-delta Ct method (∆∆Ct) was used for real-time PCR data
evaluation (Livak and Schmittgen 2001). Data was normalized for differing amounts of
input cDNA using ∆Ct (Ct for the Gapdh housekeeping gene minus Ct for the gene of
interest). Next, ∆∆Ct was calculated by subtracting the ∆Ct of each sample from the ∆Ct
of a reference liver cDNA sample run in each plate. The n-fold increase or decrease in
expression levels of each gene at each embryonic stage was calculated using the formula
2-∆∆Ct. Pair-wise comparisons were performed using the Student’s t-test. A probability of
P<0.05 was considered significant.
Results
Microarray Analysis
After applying the Benjamini-Hochberg adjustment (Benjamini and Hochberg
1995) to the p-values resulting from the comparison of chips from six donor cell lines
with six embryo chips (three SCNT and three AI) using the limma/eBayes test (Smyth
2004) for differential expression and controlling the FDR at 0.01, there were 10,942
probe sets (out of 24,128) called significantly differentially expressed between fibroblast
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donor cells and all embryos. Figure 5-1 is a volcano plot of the fibroblast/embryo
comparison. Figure 5-2 is a heatmap of five of the genes selected for further analysis.
TFAP2C was not represented on the microarray chip.

Figure 5-1 Volcano plot summarizing
results, with points colored by density.
Points above the reference line
correspond to probe sets called
significant when controlling the FDR at
0.01. Five of the genes selected for
further evaluation are highlighted. The
highlighted points are, left to right:
Thbs, Snai2, Anxa1, Oct4, Tacstd1

Figure 5-2 Heatmap of five genes of
interest. The color scale is from dark red
for low expression values to dark blue for
high expression values. The columns are
labeled ‘E’ for embryo and ‘D’ for donor
cell samples.

Q-PCR Analysis
The expression levels of Thbs, Snai2, Anxa1, Tacstd1, Oct4, and Tfap2c were
analyzed by Q-PCR in various stages of SCNT and IVF embryos as well as donor cells.
For every gene except Tacstd1 there were differences in expression levels between SCNT
and IVF embryos in multiple embryonic stages. Interestingly, these differences were
generally rectified by the blastocyst stage so SCNT and IVF embryos were
indistinguishable at the blastocyst stage for every gene except Oct4 which was expressed

134
at a lower level in SCNT embryos at every stage of development. The results of the
Q-PCR experiments are represented graphically in figure 5-3.
Thbs, Anxa1, and Snai2 exhibit similar patterns of gene regulation following
SCNT although the timing differs for each gene. In each case expression remains higher
in SCNT embryos than IVF embryos through several cell cycles- through the 4-cell stage
for Thbs1, through the 8-cell stage for Anxa1 and through the morula stage for Snai2. In
the case of Thbs1, expression is the same between SCNT and IVF embryos at the 8-cell,
morula, and blastocyst stages, Anxa1 expression is equivalent at morula and blastocyst,
and Snai2 expression remains higher in SCNT embryos until the blastocyst stage when it
is abruptly shut off. Tacstd1, Tfap2c, and Oct4 all require transcriptional induction as
embryos develop to blastocyst. In general patterns of expression in SCNT embryos
closely resemble those of IVF controls with some important differences. Expression
levels of Tacstd1 do not differ between SCNT and IVF embryos at any stage, however
Tfap2c and Oct4 both exhibit differential expression patterns. Tfap2c is detectable at the
8-cell stage in SCNT embryos but not until morula in IVF embryos, and while expression
is induced earlier in SCNT embryos it is under-expressed in SCNT morulae. Tfap2c
expression declines significantly between morula and blastocyst stages in IVF embryos
and declines to a lesser degree in SCNT morulae so that expression levels are equivalent
at the blastocyst stage. Of the six genes analyzed, Oct4 is the only one differentially
expressed at the blastocyst stage. In fact, Oct4 expression is significantly higher in IVF
embryos at every stage analyzed except in 4-cell embryos where the difference
approaches significance (P=0.082).
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Figure 5-3 Relative expression of genes based on Q-PCR. Yellow and blue bars
represent SCNT and IVF embryos respectively. Green bars represent donor cells and
oocytes. Lowercase superscripts compare SCNT embryos, and uppercase superscripts
compare IVF embryos between stages. Stages with unlike superscripts are different
(P<0.05). Asterisk indicates expression levels between SCNT and IVF embryos of the
same stage differ (P<0.05). The stage with highest expression for each gene is scaled to
1.0 on the y-axis, and other stages are scaled accordingly. Abbreviations are: Fibroblast
(Fib), Oocyte (Oo), 30 min post-fusion (30m), 12 h post-fusion/fertilization (12h), 2-cell
(2c), 4-cell (4c), 8-cell (8c), Morula (Mor), Blastocyst (Bl).
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Discussion
The microarray studies indicate that a substantial amount of reprogramming of the
donor cell genome has occurred by the blastocyst stage. Microarray analysis of donor cell
expression patterns compared with SCNT and AI blastocysts combined found differential
expression of 10,942 probe sets. Remarkably, by the blastocyst stage, a similar analysis
comparing SCNT and AI blastocysts found only 28 probe sets differentially expressed
(see Chapter 4). These results are quite similar to previously published results (Smith et
al. 2005). Despite the apparent efficiency with which the somatic cell genome is
reprogrammed by the blastocyst stage, of the six genes analyzed by Q-PCR, five were
differentially expressed at two or more stages prior to blastocyst formation. These results
indicate a substantial amount of time is required for the SCNT expression profile to
“catch up” with the profile of control embryos. This is not surprising given the fact that
the oocyte is designed to reprogram gamete nuclei, and the epigenetic modifications to
somatic cells are much different than those of germ cells. The remarkable thing is the
adaptability of the oocyte cytoplasm to successfully reprogram a variety of different
somatic cell types- albeit inefficiently. A recent study evaluating the global transcriptome
of murine SCNT embryos during the first two cell cycles also indicated a large degree of
aberrant gene expression in early mouse SCNT embryos. It was also found that
transcription of the donor cell genome continues during the first cell cycle when the
embryonic genome is typically silenced (Vassena et al. 2007).
The genes analyzed by Q-PCR were selected because they exhibited dynamic
changes in gene expression in SCNT embryos and because of their important biological
functions in early development and differentiation. OCT4 is a homeodomain transcription
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factor and a hallmark of undifferentiated stem cells. Reduced expression of Oct4 has
been shown in mouse embryos (Niwa et al. 2000) and human embryonic stem cells
(Matin et al. 2004) to result in trophoblast differentiation. Conversely, over-expression of
the gene results in differentiation of primitive endoderm and mesoderm (Niwa et al.
2000). Precise expression levels of Oct4 are clearly important in proper early embryonic
development. SNAI2 is a member of the Snail family of transcription factors that also has
important roles in early development (Cobaleda et al. 2007). It has been shown to be
required for gastrulation, epithelial-mesenchymal transition, and cell survival in the
mouse (Sefton et al. 1998). TACSTD1 is believed to be important in directing cell
migration during early development in zebrafish (Villablanca et al. 2006). TFAP2C is a
transcription factor that appears to be an important regulator of trophoblast development
and differentiation (Li and Kellems 2003). Tfap2c-null mice die around embryonic day
7.5 as a result of malformation of extra-embryonic membranes (Auman et al. 2002;
Winger et al. 2006). THBS is a secreted glycoprotein involved in cell migration and
proliferation and is apparently important in ossification, and neural and lung development
(Iruela-Arispe et al. 1993). ANXA1 is a calcium and phospholipid binding protein which
has been shown to be involved in membrane trafficking, cell division, and differentiation.
Annexins are expressed in a broad range of tissue types, possibly indicating they play
important roles in basic cell physiology (Gerke and Moss 2002).
Each of the genes analyzed is functionally important during early development,
and even transient expression differences could potentially have negative consequences
downstream. Complete nuclear reprogramming following SCNT would result in
expression profiles in SCNT embryos that mirror IVF profiles. This is not the case for
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any of the genes analyzed except for Tacstd1. Quantitative analysis of these genes
only at the blastocyst stage would indicate, with the exception of Oct4, that proper
reprogramming has occurred. Studies that evaluate gene expression only at the blastocyst
stage might underestimate the scope of reprogramming deficiencies following SCNT.
The importance of the early embryonic expression levels of the genes analyzed in this
study remains to be seen, but it is probable that any divergence from normal expression
levels at any stage of development and for any amount of time has a negative effect on
the health of the embryo. The fact that Tacstd1 was expressed normally in SCNT
embryos indicates that some genes may be more amenable to reprogramming following
SCNT than others. Understanding the properties of genes that make them more
reprogrammable might offer insights into nuclear reprogramming mechanisms.
Thbs, Snai2, and Anxa1 were all highly abundant transcripts in fibroblast donor cells, and
consequently expression continued at an above-normal level in early SCNT embryos.
This observation is in agreement with previous reports of ectopic expression of
fibroblast-specific genes following SCNT (Ng and Gurdon 2005). Following SCNT 8090% of non-histone proteins are removed from somatic nuclei effectually erasing the
somatic cell transcription program (Gurdon et al. 1979). This is followed by reestablishment of an embryonic transcription program by numerous chromatin factors
(CFs) (Gao et al. 2007). Incomplete erasure of epigenetic modifications prior to CF reestablishment is likely the cause of these patterns of over-expression. Likewise, the
differential expression of Tfap2c and Oct4 might be caused by similar deficiencies in the
process of epigenetic erasure or the subsequent process of epigenetic re-establishment
(Gao et al. 2007).
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The present study further characterizes the deficiencies associated with
nuclear reprogramming following SCNT. In addition to aberrant gene expression
(Chapter 4; Arnold et al. 2006; Herath et al. 2006; Hill et al. 2002; Humpherys et al.
2002; Li et al. 2005b; Niemann et al. 2002) and incomplete or inefficient epigenetic
modification (Alberio and Campbell 2003; Cezar et al. 2003; Enright et al. 2003; Kang et
al. 2001; Kremenskoy et al. 2006; Santos et al. 2003) following SCNT it is apparent from
this study as well as the work by Vassena et al. (2007) that the earliest embryonic stages
in SCNT embryos are highly divergent from control embryos in terms of transcriptional
profiles. The fact that these highly aberrant transcriptional profiles can be almost
completely rectified by the blastocyst stage following SCNT and a portion of these
embryos have the capacity to develop normally to term reflects the incredible plasticity of
the oocyte in its reprogramming activities. Great strides have been made in understanding
the molecular mechanisms associated with nuclear reprogramming following SCNT, and
continued progress will ultimately lead to improved SCNT efficiency as well as increased
understanding of universal epigenetic mechanisms associated with cancer and stem cell
biology as well as early development.
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CHAPTER 6
GENETIC REPROGRAMMING OF TRANSCRIPTION FACTOR AP-2γ IN
BOVINE SOMATIC CELL NUCLEAR TRANSFER
PREIMPLANTATION EMBRYOS
AND PLACENTOMES
Abstract
Bovine somatic cell nuclear transfer (SCNT) efficiency remains very low despite
a tremendous amount of research devoted to its improvement over the past decade.
Frequent early and mid-gestational losses are commonly accompanied by placental
abnormalities. A transcription factor, activating protein AP-2γ , has been shown to be
necessary for proper placental development in the mouse. We first evaluated the
expression of the gene coding for AP-2γ (Tfap2c) in several bovine fibroblast donor cell
lines and found it was not expressed. Subsequently we determined the expression profile
of Tfap2c in oocytes and various stages of pre-implantation in vitro fertilized (IVF)
embryos. Tfap2c was undetectable in oocytes and early embryos and was detectable at
relatively high levels in morula and blastocyst IVF embryos. The lack of expression in
oocytes and donor cells means Tfap2c must be induced in the zygote at the morula stage
in properly reprogrammed embryos. SCNT embryos expressed Tfap2c at the 8-cell stage,
two days earlier than control embryos. Control embryos first expressed Tfap2c at the
morula stage, and at this stage Tfap2c was significantly lower in the SCNT embryos. No
differences in expression were detected at the blastocyst stage. To determine whether
Tfap2c was properly reprogrammed in the placenta of SCNT pregnancies, we evaluated
its expression in cotyledons and caruncles of SCNT and control pregnancies between
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days 55 and 90 gestation. Expression of Tfap2c in caruncles significantly increased
between days 55 and 90, while expression in cotyledons was relatively consistent over
that same period. Expression levels in SCNT tissues were not different from controls.
This data indicates Tfap2c expression is altered in early preimplantation SCNT embryos,
which may have developmental consequences resulting from genes influenced by Tfap2c,
but expression was not different at the blastocyst stage and in placentomes.
Introduction
Since the first report of successful SCNT in sheep over a decade ago (Campbell et
al. 1996) a great deal of research has focused on SCNT in a variety of species. While new
species are added to the list of those successfully produced by SCNT on a regular basis,
very few advancements have been made to improve the efficiency of the process. The
underlying mechanisms behind the low efficiencies associated with SCNT are widely
believed to be incomplete nuclear reprogramming of the somatic cell following nuclear
transfer. During nuclear reprogramming epigenetic marks are erased from the donor
nucleus genome, resulting in an erasure of tissue-specific gene expression patterns
effectively resetting the cell to a totipotent state (Santos and Dean 2004). Studies
evaluating the epigenetic status of embryos following SCNT have demonstrated
deficiencies in epigenetic reprogramming frequently occur as manifest by aberrant gene
expression in preimplantation embryos (Arnold et al. 2006; Daniels et al. 2000; Han et al.
2003; Li et al. 2006; Santos et al. 2003) and fetuses (Arnold et al. 2006; Hill et al. 2002;
Schrader et al. 2003).
The beginnings of differentiation in the preimplantation bovine embryo occur at
the morula stage, and differentiation is visibly apparent by the blastocyst stage,
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characterized by the inner cell mass (ICM) that will develop into the embryo proper
and the surrounding trophoblast cells that give rise to extra-embryonic tissues. A number
of studies have found aberrant gene expression in bovine SCNT embryos at the blastocyst
stage (Daniels et al. 2000; Somers et al. 2006). Abnormal phenotypes associated with
SCNT likely arise as a result of incomplete nuclear reprogramming giving rise to altered
gene expression levels during early preimplantation development.
A prominent abnormal phenotype observed in SCNT pregnancies from a variety
of species is that of abnormal placentation. In cloned mice, abnormally large placentas
resulting from placental hyperplasia of basal or spongiotrophoblast layers has been
reported (Ogura et al. 2002; Ono et al. 2001). Reduced development of the
spongiotrophoblast layer has also been observed in murine SCNT pregnancies
(Wakisaka-Saito et al. 2006). Placental abnormalities associated with SCNT in ruminant
species include reduced numbers and enlargement of placentomes, avascularization or
hypovascularization, hydroallantois, and hyperplasia of fetal membranes (De Sousa et al.
2001; Hashizume et al. 2002; Hill et al. 2000; Wells et al. 1999). Poor placental
development has been reported to be a primary contributor to pregnancy failure following
SCNT (De Sousa et al. 2001; Fletcher et al. 2007; Heyman et al. 2002; Hill et al. 2000;
Loi et al. 2006).
Several groups have evaluated differential gene expression as a causative
mechanism for the frequently observed placental abnormalities. One group evaluated
expression patterns in blastocysts of several genes important in early placental
development. In this study ERR2, Cdx2, and Acrogranin were aberrantly expressed in
some of the SCNT embryos, and methods employed in the nuclear transfer process
altered expression patterns (Hall et al. 2005). Differences in mRNA expression levels for
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prolactin-related protein-1 (Prp-1), placental lactogen (Pl), and pregnancy associated
glycoproteins-1 (Pag-1) and -9 (Pag-9) were reported in placental tissues of SCNT
pregnancies between 30 and 100 days of gestation compared with controls (Patel et al.
2004). Another study evaluated expression levels of genes important in trophoblast
proliferation (Mash2), differentiation (Hand1), and function (Ifn-τ and Pag-9)
Pag in d-17
preimplantation embryos and d-40 post-implantation cotyledons. They reported increased
expression of Mash2 and reduced expression of Hand1 in SCNT embryos. In addition,
Pag-9 mRNA was undetectable in SCNT embryos but expressed in IVF and AI control
embryos. Evaluation of mRNA expression in cotyledonary tissue found both Mash2 and
Hand1 to be over-expressed in SCNT pregnancies (Arnold et al. 2006). Other groups
have evaluated binucleate cell (BNC) populations in SCNT-derived cotyledons with
mixed results. In ruminant species BNCs present at the fetomaternal interface play
critical roles in pregnancy maintenance by producing and secreting proteins necessary for
pregnancy establishment and maintenance such as Pl, Prps, and Pags (Hashizume et al.
2007). BNCs in ruminant species are analogous to trophoblast giant cells (TGCs) in mice
and are believed to arise from endoreplication and acytokinesis of mononucleate cells
(MNCs) (Nakano et al. 2002). Increased numbers (Ravelich et al. 2004), normal numbers
(Hoffert et al. 2005), and reduced numbers (Arnold et al. 2006) of BNCs have all been
reported in bovine SCNT placentomes, so the involvement of BNCs in abnormal
placental development and function in bovine SCNT pregnancies is unclear.
Another gene shown to be critical in differentiation of extra-embryonic tissues
and expressed in TGCs in mice is Tfap2c which codes for the transcription factor AP-2γ
(Auman et al. 2002). The AP-2 family of transcription factors includes AP-2α , β , γ , and δ .
AP-2 proteins have been shown to be involved in regulation of cell proliferation,
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differentiation, and tumor progression (Auman et al. 2002). AP-2γ in particular has
been demonstrated to be intimately involved in proper placental development and
function. In the mouse, AP-2γ is expressed in the oocyte, and the maternally-derived
maternally
transcript persists through the 2-cell stage. As maternal transcript declines rapidly zygotic
transcription of the gene is initiated, so AP-2γ is present at relatively high levels through
the blastocyst stage (Winger et al. 2006). The transcription factor has been shown in mice
to be required for normal development of extra-embryonic membranes, and Tfap2c-/- mice
fail to develop a functional placenta and generally do not survive beyond 7.5 days postcoitus (d.p.c.) (Auman et al. 2002; Winger et al. 2006). Normal embryos at 7.5 d.p.c.
contained 50-60 TGCs, while mutant embryos contained as few as two. In addition,
disorganization of extra-embryonic ectoderm, lack of exocoelemic and ectoplacental
cavity formation, and reduced or absent ectoplacental cones were reported (Auman et al.
2002; Winger et al. 2006). In a recent study analyzing global gene expression patterns in
bovine placenta throughout gestation Tfap2c was found to be expressed in MNCs but not
in BNCs, an important difference between murine and bovine Tfap2c expression
(Ushizawa et al. 2007).
Given the importance of Tfap2c demonstrated in murine placental development
along with the numerous reports of placental abnormalities in bovine SCNT pregnancies,
we undertook to investigate the involvement of Tfap2c in early embryonic development
and placental function in cattle. The goal of the present study was to evaluate expression
patterns of Tfap2c in control preimplantation embryos and placental tissues as well as
donor cells, SCNT embryos, and placental tissues collected from SCNT pregnancies in
order to determine whether aberrant expression of the transcription factor might be
implicated in the abnormal placental development observed in bovine SCNT pregnancies.

154
We characterized temporal expression patterns of Tfap2c in early stages of
preimplantation bovine IVF and SCNT embryos and in cotyledonary and caruncular
tissue derived from AI and SCNT pregnancies between days 55 and 90 of gestation.
Tfap2c expression was analyzed in fibroblast donor cells, oocytes, and in IVF and
SCNT embryos 12 h post-fertilization/activation and at the 2-cell, 4-cell, 8-cell, morula,
and blastocyst stages. This work was undertaken in an effort to gain insight into the
timing of gene expression regulation following SCNT with the ultimate goal of
elucidating reprogramming mechanisms. Tfap2c expression was futher analyzed in
SCNT and control cotyledons and caruncles between 55 and 90 days gestation. This is
the first study to report detailed stage-by-stage gene expression levels in preimplantation
bovine SCNT embryos as well as the first to evaluate Tfap2c expression in SCNT
placental tissues.
Materials and Methods
Donor Cell Culture
Primary bovine fibroblast cultures were established from lung tissue. Tissues
were washed thoroughly and minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone
Laboratories, Logan, UT 84321) supplemented with 15% fetal bovine serum (FBS;
HyClone Laboratories) and 100 U/mL penicillin/ 100 µg/mL streptomycin (HyClone
Laboratories), seeded in 25 cm2 tissue culture flasks, and cultured at 39˚C in a humidified
atmosphere of 5% CO2 in air for several days. Cells between passages one and four were
then harvested and re-suspended in tissue culture medium containing 10% DMSO and
stored in liquid N2 until use in SCNT. Prior to SCNT cells were thawed and grown to 80100% confluence. Cells were subsequently harvested by trypsinization and re-suspended
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in manipulation medium for use in SCNT.
Oocyte Maturation
Maturation of bovine oocytes was performed as described previously (Li et al.
2004a; Li et al. 2004b). Briefly, cumulus oocyte complexes (COC) were aspirated from
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.
Only those oocytes with uniform cytoplasm and intact layers of cumulus cells were
selected and matured in TCM 199 containing 10% FBS, 0.5 µg/mL FSH (Sioux
Biochemicals, Sioux City, IA 51250), 5 µg/mL LH (Sioux Biochemicals), and 100 U/mL
penicillin/ 100 µg/mL streptomycin for 18-22 h.
SCNT Embryo Production
Following maturation, cumulus cells were removed from oocytes by vortexing
COC in PB1 (calcium and magnesium containing phosphate buffered saline [HyClone
Laboratories], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/mL BSA) medium
containing 10 mg/mL hyaluronidase. Oocytes with a first polar body were used as
recipient cytoplasts. Enucleation was employed to remove the first polar body and
metaphase plate, and single cells were subsequently transferred to the perivitelline space
of recipient cytoplasts. Fusions of NT couplets were performed in mannitol fusion
medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25 microseconds.
Following fusion, embryos were held in CR2 medium supplemented with 3% FBS for 12 h prior to activation. Fused embryos were activated between 23 and 25 h after the onset
of maturation by exposure to 5 µM ionomycin for 5 min followed by 5 h incubation in
10µg/ml cycloheximide. Three groups of five embryos each were collected at each
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embryonic stage to be analyzed. Embryos were placed in RNAlater RNA stabilization
reagent (Ambion Inc., Austin, TX 78744) and stored at -20° C until RNA extraction.
IVF Embryo Production
Cyropreserved bovine semen (Hoffman AI, Logan, UT) was thawed and live
sperm were separated by centrifugation on a 45%/95% layered Percoll gradient. Motile
spermatozoa obtained by this method were diluted in fert-TALP to a final concentration
of 1.0 X 106 per ml (Reed et al. 1996). Capacitation occurred in fert-TALP containing
heparin at a concentration of 10 µg/ml. In-vitro matured oocytes were fertilized in vitro
for 18-20 h at 39°C in 5% CO2 and air. After the fertilization period, oocytes were
vortexed in a 15-ml conical centrifuge tube containing 1 ml of PB1 2 min 40 sec to
completely remove cumulus cells. Embryos were co-cultured with cumulus cells in CR2
medium supplemented with 3% FBS (Rosenkrans and First 1994) at 39°C in 5% CO2.
Three groups of five embryos each were collected at each embryonic stage to be
analyzed. Embryos were rinsed through several drops of PB1 and through a single drop
of RNAlater then placed in RNAlater (Ambion Inc.) and stored at -20° C until RNA
extraction.
Cotyledon and Caruncle Collection
Control pregnancies were either established by artificial insemination of CIDRsynchronized cows or collected from the abattoir and aged based on crown-rump
measurements, and SCNT pregnancies were established by non-surgical embryo transfer
of day 7-8 SCNT blastocysts. Pregnancies were monitored by ultrasound around
embryonic day-30 and again around day-60 and day-90. Recipient animals were
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slaughtered at a local abattoir. Cotyledon and caruncle tissues were collected within
thirty min of slaughter, snap frozen and stored in cryovials in liquid N2 until RNA
extraction. Cotyledons were collected from nine control pregnancies (days 54, 56, 60, 69,
70, 75, 83, 90, and 91) and seven SCNT pregnancies (days 69, 70(3), 89(2), and 90).
RNA Extraction
RNA extraction from embryos. Total RNA was extracted and DNA was digested
with DNase I IVF, and NT embryos using the RNAqueous micro kit (Ambion Inc.)
according to manufacturer’s recommendations with modifications. Prior to RNA
extraction each sample was spiked with 50 µg yeast tRNA as a carrier. RNA was eluted
from the RNAqueous column using two 20-µll volumes of pre-warmed
pre
(75° C) elution
solution. Following RNA purification samples were immediately reverse-transcribed and
stored at -20ºC until Q-PCR analysis.
RNA extraction from cotyledons and caruncles. Cotyledons were removed from
liquid N2, and approximately thirty mg of tissue was placed in RLT Buffer (Qiagen Inc.,
Valencia, CA 91355) containing beta-mercapto ethanol (βME) and subsequently
homogenized using a rotor stator homogenizer. RNA extraction was performed using the
RNeasy Mini RNA Extraction Kit (Qiagen) according to manufacturer’s
recommendations.
Reverse Transcription and
SYBR Green Q-PCR
Reverse transcription was performed using Superscript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA 92008) with random primers. cDNA was stored at -20°C until
use. SYBR Green real-time PCR (Abgene, Rochester, NY 14610) was used to evaluate
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Tfap2c expression in cotyledons, caruncles and preimplantation embryos. Each realtime PCR reaction was performed in duplicate. Q-PCR was performed in white thinwalled 96-well plates. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was be
used as the internal control housekeeping gene as it has been determined to be the most
reliable housekeeping gene in bovine preimplantation embryos (Robert et al. 2002).
Primers for Q-PCR analysis were designed using Primer3 primer-design software (Rozen
and Skaletsky 2000). The primer sequences were as follows: GAPDH forward: GAT
TGT CAG CAA TGC CTC CT, GAPDH reverse: TTG AGC TCA GGG ATG ACC TT,
Tfap2c forward: CTG CTC AGT CCC TGG AAG AC, and Tfap2c reverse: AAG GTA
CGG CCA CCA TTT TT. A standard PCR protocol with a 15µL reaction volume was
used. The reactions consisted of Absolute™ QPCR SYBR® Green PCR Master Mix
(Abgene) containing fluorescein reference dye, forward and reverse primers at 200 nM
final concentration and 1 µL diluted template cDNA. The same PCR protocol was used
for all primers: 15 min at 95°C for activation of the hot start Thermo-Start® DNA
Polymerase; 40 cycles of 95°C for 15 sec, 58°C for 30 sec, and 72°C for 15 sec (data
collection step), then 95°C for 30 sec followed by an 80-cycle melt curve initiated by 30
sec at 55°C with a temperature increase of 0.5°C each cycle.
Statistical Analysis
The delta-delta Ct method (∆∆Ct) was used for real-time PCR data evaluation
(Livak and Schmittgen 2001). Data was normalized for differing amounts of input cDNA
using ∆Ct (Ct for the GAPDH housekeeping gene minus Ct for the gene of interest).
Next, ∆∆Ct was calculated by subtracting the ∆Ct of each sample from the ∆Ct of a
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reference cDNA sample. The n-fold increase or decrease in expression levels of each
gene at each embryonic stage was calculated using the formula 2-∆∆Ct. Pair-wise
comparisons between SCNT- and AI-∆∆Ct values were performed for each gene using
the Student’s t-test. A probability of P<0.05 was considered significant.
Results
Tfap2c Expression in Fibroblast
Donor Cells
Initially several fibroblast donor cell lines which have been used successfully in
our laboratory were analyzed for Tfap2c expression. Tfap2c was not detected in any of
the cell lines analyzed. Figure 6-1 indicates pregnancy rates and rates of development to
term of SCNT embryos derived from the cell lines analyzed. Twenty or more embryo
transfers were performed for each of the cell lines represented. Subsequent analysis of
gene expression was performed on embryos and placental tissue derived from the cell
line labeled “444”.
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Figure 6-1 Pregnancy rates of four fibroblast cell lines analyzed for the expression of
Tfap2c. White bars represent the proportion of pregnancies detected at embryonic day30, and black bars represent proportion of embryo transfers resulting in term deliveries.
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Tfap2c Expression in Preimplantation IVF
and SCNT Embryos
Oocytes and embryos were pooled in groups of five to provide sufficient RNA for
reverse transcription and Q-PCR analysis without the need for linear amplification, and
the pooling of embryos served to minimize variability between replicates. Unlike Tfap2c
expression in murine oocytes and preimplantation embryos, the transcript was not
detectable by Q-PCR analysis in bovine oocytes or early preimplantation SCNT or
control embryos. In control embryos the gene was first detectable in morulae at high
levels. Transcript abundance declined quite dramatically between morula and blastocyst.
In contrastTfap2c expression in SCNT embryos was detectable approximately 48 h
earlier in 8-cell embryos. While expression increased between 8-cell and morula, Tfap2c
expression was significantly lower in SCNT morulae compared with IVF. Expression
declined in to a lesser degree in SCNT blastocysts, so at the blastocyst stage Tfap2c
expression was equivalent to IVF embryos (Figure 6-2).
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Figure 6-2 Relative expression of Tfap2c in early preimplantation embryos. White
bars represent SCNT embryos, and black bars represent IVF embryos.
*- Expression differs significantly within stages between IVF and SCNT embryos.
(P<0.05)
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Tfap2c Expression in AI and SCNT Cotyledons and Caruncles
Between days 55 and 85 of gestation Tfap2c expression remained constant in
cotyledons (Figure 6-3) whereas expression increased in caruncles over the same time
period (Figure 6-4). Tfap2c expression was higher in cotyledons than caruncles at every
stage analyzed however, the difference in expression between the two tissues decreased
as pregnancy progressed. SCNT and AI caruncles and cotyledons did not differ
significantly in Tfap2c expression levels based on Q-PCR analysis.
Discussion
Thirty-day and term pregnancy rates of SCNT embryos derived from the four
donor cell lines analyzed were similar to those reported by other laboratories (Oback and
Wells 2007). Tfap2c transcript was not detectable by Q-PCR in any of the bovine
fibroblast cell lines analyzed. Previously it was reported that Tfap2c is likewise not
expressed in mouse embryo fibroblasts (Winger et al. 2006).
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Figure 6-3 Relative expression of Tfap2c
in cotyledons. White bars represent
SCNT, and black bars represent AI.
SCNT placental tissues were not available
for analysis at day 55.
a-Bars with unlike subscripts are different
(P<0.05)
*-Ranges for the above time points are 5460, 69-75, and 83-91.
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Figure 6-4 Relative expression of Tfap2c
in caruncles. White bars represent SCNT,
and black bars represent AI. SCNT
placental tissues were not available for
analysis at day 55.
b-Bars with unlike subscripts are different
(P<0.05)
*-Ranges for the above time points are 5460, 69-75, and 83-91.

Subsequent analysis of Tfap2c expression in oocytes and control preimplantation
revealed several important differences from previous reports in the mouse. Tfap2c was
not detectable in bovine oocytes nor was it expressed in early preimplantation embryos.
The first stage in which Tfap2c was detectable in bovine IVF embryos was morula,
where it was highly expressed. It remained detectable in control bovine blastocysts but at
a reduced level. In the mouse Tfap2c is expressed in oocytes and at relatively constant
levels in oocytes, 2-cell and 4-cell embryos, morulae, and blastocysts (Winger et al.
2006).
Following fertilization maternal proteins and mRNAs direct embryo development
until zygotic genome activation (ZGA). Following ZGA many of the maternal RNAs are
degraded, and gene expression and embryo development are primarily under the control
of the zygotic genome (Schier 2007). ZGA occurs at the 2-cell stage in mice (Zeng and
Schultz 2005) and at the 8-cell stage in cattle (Memili and First 2000), however a limited
amount of zygotic transcription occurs prior to ZGA (Schultz 2002). Analysis of Tfap2c
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expression in mouse preimplantation embryos has demonstrated that the transcript
present prior to ZGA is maternally derived, and following ZGA, maternal Tfap2c
declines rapidly, and zygotic Tfap2c is actively transcribed (Winger et al. 2006). The
differences in Tfap2c expression in murine and bovine preimplantation embryos likely
reflect the differences in timing of ZGA.
During the earliest stages of cell division and differentiation the embryonic
program utilizes unique mechanisms of gene regulation. Experiments utilizing luciferase
reporter genes under the control of a thymidine kinase promoter with and without an
enhancer site provided the first evidence for a transcriptionally repressive state
characterized by an increased requirement for enhancers in preimplantation mouse
embryos following ZGA (Wiekowski et al. 1991). Attenuated response to promoters and
increased dependence on enhancers for transcriptional activation has also been reported
in rabbit preimplantation embryos (Christians et al. 1994). Other studies have
demonstrated a shift in TATA box requirements of some genes in preimplantation
embryos. While differentiated cells generally utilize TATA-containing promoters to drive
gene expression, TATA-less promoters seem to be more efficiently used following ZGA
(Davis and Schultz 2000). Significantly, Tfap2c expression has been shown to be under
the control of a TATA-less promoter (Li and Kellems 2003). The expression patterns
observed in preimplantation bovine embryos suggest Tfap2c expression is tightly
regulated in the early embryo. Its function as a transcription factor regulated by a TATAless promoter as well as its precise and rapid induction at the morula stage suggest its
important involvement in early differentiation events.
The unique expression profiles of Tfap2c in fibroblasts, oocytes, and
preimplantation embryos as well as the functional importance of AP-2γ as a transcription
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factor critical for placental development and function compelled us to evaluate its
expression in preimplantation SCNT embryos. Since Tfap2c is not detectable in donor
cells or oocytes, any subsequent expression in SCNT embryos must be a consequence of
some reprogramming event following SCNT. The timing of the induction of the
transcription factor in SCNT embryos is certainly important for proper embryo
development and differentiation.
We analyzed Tfap2c expression in preimplantation SCNT embryos and found the
gene to be detectable in 8-cell embryos- about 48 h prior to the first detectable expression
in IVF embryos. Expression increased between the 8-cell stage and morula, but transcript
abundance in SCNT morulae was less than half that of IVF morulae. The decline in
Tfap2c expression between morula and blastocyst SCNT embryos was less marked than
in IVF embryos so that by the blastocyst stage Tfap2c expression was equivalent in IVF
and SCNT embryos.
The early induction of Tfap2c in SCNT embryos as well as lower expression in
SCNT morulae is likely indicative of abnormal gene regulation during the critical period
of ZGA. While the differences in Tfap2c expression observed between SCNT and IVF
preimplantation embryos appear relatively minor, and no difference in expression of the
gene is observed in IVF and SCNT embryos by the blastocyst stage, these transient
differences could have a profound impact the expression of a host of other genes
important in early development. Early studies involving the characterization of the
transcriptional control following ZGA suggested broad and somewhat indiscriminate
genome activation, however, more recent transcriptional profiling studies indicate ZGA is
a tightly controlled event in which a very specific sub-set of genes important in early
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development are activated, particularly genes involved in transcription and RNA
processing (Ko et al. 2000; Wang et al. 2004; Zeng and Schultz 2005).
Subtle differences in timing and levels of expression of transcription factors such
as Tfap2c in early preimplantation embryos could affect the timing and level of
expression of numerous other genes downstream. Analysis of Tfap2c transcript
abundance at various stages of preimplantation development further demonstrates that
while expression analysis in blastocysts may indicate proper reprogramming has occurred
following SCNT, expression analysis in earlier embryonic stages might indicate the
opposite to be true. Global expression analysis of cloned mouse embryos during the first
two cell cycles indicated differential gene expression in early SCNT embryos might be
the rule rather than the exception (Vassena et al. 2007). Given the apparent precision by
which gene expression is controlled following ZGA, it is clear that perturbations in
timing of gene expression may be as important developmentally as aberrant expression in
SCNT blastocyst-stage embryos.
Numerous reports of abnormal placental development in SCNT pregnancies exist.
In cattle, reduced numbers of abnormally large placentomes have been observed. In
addition hypovascularization and hyperplasic fetal membranes as well as increased
incidence of hydroallantois have been reported (Hashizume et al. 2002; Hill et al. 2000).
Various studies have reported abnormal gene expression in SCNT-derived placentas
(Arnold et al. 2006; Oishi et al. 2006; Patel et al. 2004). Other groups have evaluated
binucleate cell (BNC) populations in SCNT-derived cotyledons with mixed results.
Increased numbers (Ravelich et al. 2004) normal numbers (Hoffert et al. 2005) and
reduced numbers (Arnold et al. 2006) of BNCs have all been reported in SCNT
placentomes. As BNCs are derived from MNCs, evaluation of expression of a MNC-
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derived transcript in SCNT placental tissue might offer insight into the problems
associated with SCNT placental function.
The expression of Tfap2c was analyzed in control and SCNT cotyledons and
caruncles to determine whether aberrant expression might account for some of the
abnormalities commonly associated with SCNT placentomes. Our analysis of Tfap2c
expression in control cotyledons and caruncles substantiated a recent report (Ushizawa et
al. 2007). The transcript was detected in both cotyledons and caruncles collected from
pregnancies between days 55 and 90. In agreement with the previous report, Tfap2c was
expressed at constant levels in all cotyledons analyzed, while expression in caruncles
increased steadily over the same period. These patterns of expression (constant in
cotyledons and increasing in caruncles) have been shown to continue at least through day
250 gestation (Ushizawa et al. 2007). By day-250, expression levels are equivalent
between cotyledons and caruncles. Interestingly, Tfap2c expression in cotyledons and
caruncles derived from SCNT pregnancies around day-70 and day-90 was very closely
correlated with Tfap2c expression in controls, an indication that Tfap2c expression levels
in placentomes are probably not a causative agent in abnormal SCNT placentation. As
Tfap2c expression was found to be exclusive to MNCs (Ushizawa et al. 2007), similar
levels of Tfap2c expression in SCNT and control placentomes likely indicates normal
MNC number and function in SCNT placentomes, at least in the context of this study.
The normal levels of Tfap2c expression in SCNT cotyledons and caruncles does
not preclude its involvement in the placental abnormalities frequently observed in bovine
SCNT pregnancies. As discussed previously, aberrant expression of transcription factors
in early embryos could have numerous downstream consequences. It is likely the gene
expression profiles during early differentiation have a greater impact on placental
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morphology and function than expression in differentiated placental tissue. In order
for proper placental development to occur the initial signals for placental differentiation
must be present. Reduced placentome numbers and altered function are certainly
consequences of inappropriate gene expression prior to implantation when differentiation
of trophectodermal lineages along with embryo-uterine signaling results in the union of
fetal and maternal tissues and the establishment of placentomes. In cattle, implantation is
initiated around day-25 gestation (Hashizume 2007), so correct expression of genes
involved in placental function and implantation prior to this time are of critical
importance in proper placental function. Further research of gene expression in pre- and
peri-implantation bovine SCNT-derived tissues will be important in elucidating genes
expression patterns associated with abnormal placentation.
The data presented here provides impetus for the continued evaluation of gene
expression in early preimplantation SCNT embryos prior to the blastocyst stage,
particularly genes associated with ZGA. Clearly there remains a great deal we do not
understand in regards to mechanisms involved in nuclear reprogramming and the
functional importance of timing of gene expression during early embryogenesis, and
continued research in this area will help in answering these questions. In addition this
data offers important insights into potential roles of Tfap2c in early embryonic
development and placentome function. Functional studies in cattle will be important in
elucidating the roles of Tfap2c in development and differentiation of extra-embryonic
tissues in bovine pregnancies.
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CHAPTER 7
SUMMARY
A great deal of research over the past decade has been focused on improving the
efficiency of bovine SCNT, characterizing deficiencies in the process that impact
efficiency, and finally understanding the mechanisms by which the oocyte successfully
reprograms somatic cell nuclei to give rise to a complete organism from what was once
believed to be terminally differentiated cell types. To date, the efficiency of the process
remains quite low, though limited advances have been made in that regard. Numerous
studies have added to the growing body of information regarding differences between
SCNT and control embryos and fetuses. These studies have reported differences in
epigenetic status of SCNT embryos as well as altered patterns of gene expression and
phenotypic differences in SCNT embryos and fetuses. Advances are being made to
understand the mechanisms of epigenetic reprogramming employed by the oocyte
following SCNT, but progress in this area is incremental.
The experiments reported in this dissertation identify factors associated with
oocyte source as well as timing of activation following nuclear transfer that result in
improved efficiencies. In addition, several aberrantly expressed genes are identified in
somatic cell nuclear transfer blastocysts and cotyledons that could have an impact on
cloning efficiency. The expression levels of six developmentally important genes were
analyzed in various stages of preimplantation nuclear transfer embryos using QPCR in
order to determine the timing of nuclear reprogramming following nuclear transfer. These
experiments report factors associated with improved bovine somatic cell nuclear transfer
efficiency, provide insight into potential mechanisms for low developmental rates,
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abnormal placentation and fetal loss of bovine clones, and characterize the timing of
nuclear reprogramming in preimplantation embryos of several important genes following
somatic cell nuclear transfer.
Evaluation of embryo development and pregnancy data representing several
thousand SCNT embryos indicated the time interval between nuclear transfer and
activation was critical for optimal in vitro embryo development. Further experimentation
indicated the effect was due, at least in part, to altered chromatin morphology in an
increasing proportion of embryos as the time interval between fusion and activation
increased. Embryos activated between one and two h after fusion exhibited higher
cleavage and compacted morula/blastocyst rates than embryos held three h or longer
between fusion and activation. We evaluated chromatin structure and pronuclear
formation in embryos held between two and five h between fusion and activation and
found normal chromatin condensation occurred at a significantly lower rate in embryos
held three h or longer prior to fusion. In addition fragmentation of nuclei tended to
increase with prolonged fusion/activation intervals. Interestingly, embryos that developed
to compacted morula/blastocyst established pregnancies at equivalent rates following
embryo transfer. Based on this data we concluded that embryos that are chromosomally
compromised probably cease development prior to reaching compacted morula stage.
The data further indicated that 1 h between fusion and activation provides the donor
nucleus with sufficient exposure to MII cytoplasm to initiate critical reprogramming
events and that longer than two h results in reduced viability of embryos in vitro.
Further evaluation of in vitro development and pregnancy data along with
anecdotal reports from other researchers in the field of bovine SCNT indicated a
significant affect of oocyte source on SCNT efficiency. We compared in vitro
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development rates as well as pregnancy rates of SCNT embryos derived from heifer
oocytes and cow oocytes and found significant improvements in development in vitro and
in vivo in embryos derived from cow oocytes. We found a significantly higher
proportion of embryos derived from cow oocytes cleaved and further developed to
compacted morula/blastocyst. In addition, following transfer of these embryos to
recipient animals, a higher initial pregnancy rate and significantly increased pregnancy
retention was observed. These data demonstrated that when possible cow oocytes should
be utilized for bovine NT experiments over heifer oocytes. The study also indicated that
heifer oocytes are capable of reprogramming donor nuclei and producing live SCNT
offspring, albeit at a much lower rate.
A second facet of the research reported in this dissertation was the identification
of factors associated with deficiencies in nuclear reprogramming that resulted in poor
SCNT efficiency. As reduced rates of in vitro development and pregnancy establishment
with SCNT embryos had been reported previously, we undertook to characterize global
gene expression differences between SCNT and control blastocysts with the goal of
identifying gene expression differences that might account for the phenotypic differences
observed. In addition, the common observation in our own research group as well as in
the literature of abnormal placentation associated with SCNT pregnancies lead us to
perform similar global gene expression experiments on cotyledonary tissues collected
from control and SCNT pregnancies. The results of these experiments revealed a
relatively small number of aberrantly expressed genes in SCNT embryos and cotyledons.
The most promising genes determined to be differentially expressed in SCNT blastocysts
were Dr1 and MHCI. DR1 binds to the TATA binding protein (TBP) and blocks the
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binding of RNA polymerases II and III. In this way, DR1 can act as a potent
transcriptional regulator. If Dr1 is commonly over-expressed in SCNT embryos it could
have a profound impact on transcriptional regulation in early embryos. MHCI molecules
serve as important antigen presenting cells in the immune response. The over-expression
of MHCI in the bovine SCNT placentas has been reported previously, and immune
rejection of the pregnancy by the dam resulting in placental MHCI expression has been
proposed as a factor in the frequent losses in bovine SCNT pregnancies. In the cotlyledon
expression studies, Rbp1 was found to be over-expressed in SCNT cotyledons. RBP1
serves as the carrier protein for retinol (vitamin A), a vitamin critical for normal
embryonic development. Proper doses of vitamin A are critical for normal embryonic
development, and either an excess or a deficiency has been shown to result in embryonic
defects. Functional studies evaluating the involvement of these genes in SCNT
embryonic and placental development and function will be insightful.
In order to better understand the dynamics by which nuclear reprogramming
occurs following SCNT, we used microarray analysis to identify a number of genes that
underwent a high degree of change in expression by the blastocyst stage following
SCNT. We selected six functionally important genes to further investigate, three of which
underwent down-regulation following SCNT and three that were up-regulated. Using
QPCR we followed the expression levels of these genes through early embryonic stages
to identify temporal differences in expression in SCNT embryos compared with IVF
embryos. We found that five of the six genes analyzed exhibited altered levels of
expression at some stage of preimplantation development. Only one of the six genes was
aberrantly expressed by the blastocyst stage. These results indicate that experiments
evaluating gene expression differences between control and SCNT blastocysts may
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underestimate the degree of difference between clones and controls and further offer
insights into the dynamics of gene reprogramming following SCNT.
One of the genes evaluated in the reprogramming study, Tfap2c was investigated
further because of its importance as a transcription factor in development and
differentiation of extra-embryonic tissues. We analyzed Tfap2c expression levels in
control and SCNT cotyledons collected from day-55 to day-90 pregnancies. We found
that expression was relatively high and maintained at constant levels in cotyledons and
that it was lower and increased over the same period in caruncles. No difference in
expression levels was observed in SCNT cotyledons and caruncles, evidence that Tfap2c
expression levels do not account for the reduced placental function in bovine SCNT
pregnancies.
Further research will be required to determine factors that impact the efficiency
with which DNA is reprogrammed following SCNT. The data presented here includes a
group of differentially expressed genes whose aberrant expression likely impacts SCNT
efficiency negatively. Whether these differentially expressed genes work in concert with
one another or independently is unclear, but it is likely the affects of aberrant gene
expression are cumulative. Several of the genes identified herein as differentially
expressed in SCNT blastocysts or cotyledons are certainly of physiological importance,
and further investigation into their involvement in SCNT inefficiency is warranted.
Additionally, the data associated with reprogramming dynamics following SCNT
provides several important insights into reprogramming mechanisms. The observation
that the timing of gene activation or suppression varies between genes indicates the
timing of reprogramming is gene-dependent. It is probable that the epigenetic architecture
of specific genes in the donor cell dictates the efficiency with which each genes is
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reprogrammed. This data also provides the first detailed analysis of gene expression
in multiple pre-implantation stages of SCNT and IVF embryos and indicates the
divergence in gene expression patterns is very high in early SCNT embryos and narrows
greatly by the blastocyst stage.
Together these data represent a significant contribution to the field of bovine
SCNT. We have identified factors important in SCNT efficiency as well as several
aberrantly expressed genes in SCNT embryos and cotyledons that might account for
some of the inefficiencies associated with SCNT. In addition, high resolution analysis of
expression patterns of developmentally important genes in preimplantation embryos
provides significant insight into the poorly understood mechanisms of nuclear
reprogramming following SCNT. Continued research is required, particularly in the area
of nuclear reprogramming in order to better understand the mechanisms involved and
ultimately make SCNT a more efficient process.
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